Thomas Helleday

About me
Publications
CV
Public outreach and news

About me

Professor of Chemical Biology

Articles

Article: BLOOD. 2023;141(26):3166-3183

Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL.

Largeot A; Klapp V; Viry E; Gonder S; Fernandez Botana I; Blomme A; Benzarti M; Pierson S; Duculty C; Marttila P; Wierz M; Gargiulo E; Pagano G; An N; El Hachem N; Perez Hernandez D; Chakraborty S; Ysebaert L; François J-H; Cortez Clemente S; Berchem G; Efremov DG; Dittmar G; Szpakowska M; Chevigné A; Nazarov PV; Helleday T; Close P; Meiser J; Stamatopoulos B; Désaubry L; Paggetti J; Moussay E
Article: ONCOGENE. 2023;42(16):1282-1293

NUDT22 promotes cancer growth through pyrimidine salvage.

Walter M; Mayr F; Hanna BMF; Cookson V; Mortusewicz O; Helleday T; Herr P
Article: NATURE METABOLISM. 2023;5(4):642-659

Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells.

Green AC; Marttila P; Kiweler N; Chalkiadaki C; Wiita E; Cookson V; Lesur A; Eiden K; Bernardin F; Vallin KSA; Borhade S; Long M; Ghahe EK; Jiménez-Alonso JJ; Jemth A-S; Loseva O; Mortusewicz O; Meyers M; Viry E; Johansson AI; Hodek O; Homan E; Bonagas N; Ramos L; Sandberg L; Frödin M; Moussay E; Slipicevic A; Letellier E; Paggetti J; Sørensen CS; Helleday T; Henriksson M; Meiser J
Article: JOURNAL OF TRANSLATIONAL MEDICINE. 2023;21(1):169

Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming.

Pateras IS; Williams C; Gianniou DD; Margetis AT; Avgeris M; Rousakis P; Legaki A-I; Mirtschink P; Zhang W; Panoutsopoulou K; Delis AD; Pagakis SN; Tang W; Ambs S; Warpman Berglund U; Helleday T; Varvarigou A; Chatzigeorgiou A; Nordström A; Tsitsilonis OE; Trougakos IP; Gilthorpe JD; Frisan T
Article: NATURE COMMUNICATIONS. 2023;14(1):643

Small-molecule-mediated OGG1 inhibition attenuates pulmonary inflammation and lung fibrosis in a murine lung fibrosis model.

Tanner L; Single AB; Bhongir RKV; Heusel M; Mohanty T; Karlsson CAQ; Pan L; Clausson C-M; Bergwik J; Wang K; Andersson CK; Oommen RM; Erjefält JS; Malmström J; Wallner O; Boldogh I; Helleday T; Kalderén C; Egesten A
Article: CHEMMEDCHEM. 2023;18(1):e202200310

Optimization of N-Piperidinyl-Benzimidazolone Derivatives as Potent and Selective Inhibitors of 8-Oxo-Guanine DNA Glycosylase 1.

Wallner O; Cázares-Körner A; Scaletti ER; Masuyer G; Bekkhus T; Visnes T; Mamonov K; Ortis F; Lundbäck T; Volkova M; Koolmeister T; Wiita E; Loseva O; Pandey M; Homan E; Benítez-Buelga C; Davies J; Scobie M; Warpman Berglund U; Kalderén C; Stenmark P; Helleday T; Michel M
Article: INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. 2023;37:3946320231158025-039463202311580

Infiltrating immune cells in prostate cancer tissue after androgen deprivation and radiotherapy.

Erlandsson A; Lundholm M; Watz J; Bergh A; Petrova E; Alamdari F; Helleday T; Davidsson S; Andren O; Tarish F
Article: CELLS. 2022;11(24):4121

An Approach for Systems-Level Understanding of Prostate Cancer from High-Throughput Data Integration to Pathway Modeling and Simulation.

Mobashir M; Turunen SP; Izhari MA; Ashankyty IM; Helleday T; Lehti K
Article: BIOMOLECULES. 2022;12(12):1777

Overexpressed c-Myc Sensitizes Cells to TH1579, a Mitotic Arrest and Oxidative DNA Damage Inducer.

Henriksson S; Calderón-Montaño JM; Solvie D; Warpman Berglund U; Helleday T
Article: JOURNAL OF HEPATOLOGY. 2022;77(5):1311-1324

NUDT1 promotes the accumulation and longevity of CD103+ TRM cells in primary biliary cholangitis.

Huang B; Lyu Z; Qian Q; Chen Y; Zhang J; Li B; Li Y; Liang J; Liu Q; Li Y; Chen R; Lian M; Xiao X; Miao Q; Wang Q; Fang J; Lian Z; Li Y; Tang R; Helleday T; Gershwin ME; You Z; Ma X
Article: NATURE COMMUNICATIONS. 2022;13(1):5475

Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones.

Marklund M; Schultz N; Friedrich S; Berglund E; Tarish F; Tanoglidi A; Liu Y; Bergenstråhle L; Erickson A; Helleday T; Lamb AD; Sonnhammer E; Lundeberg J
Article: CHEMMEDCHEM. 2022;17(18):e202200274

The First Structure of Human MTHFD2L and Its Implications for the Development of Isoform-Selective Inhibitors.

Scaletti ER; Gustafsson Westergren R; Andersson Y; Wiita E; Henriksson M; Homan EJ; Jemth A-S; Helleday T; Stenmark P
Article: NATURE. 2022;608(7922):360-367

Spatially resolved clonal copy number alterations in benign and malignant tissue.

Erickson A; He M; Berglund E; Marklund M; Mirzazadeh R; Schultz N; Kvastad L; Andersson A; Bergenstråhle L; Bergenstråhle J; Larsson L; Alonso Galicia L; Shamikh A; Basmaci E; Díaz De Ståhl T; Rajakumar T; Doultsinos D; Thrane K; Ji AL; Khavari PA; Tarish F; Tanoglidi A; Maaskola J; Colling R; Mirtti T; Hamdy FC; Woodcock DJ; Helleday T; Mills IG; Lamb AD; Lundeberg J
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2022;298(8):102169

Nudix hydrolase 18 catalyzes the hydrolysis of active triphosphate metabolites of the antivirals remdesivir, ribavirin, and molnupiravir.

Jemth A-S; Scaletti ER; Homan E; Stenmark P; Helleday T; Michel M
Article: SCIENCE. 2022;376(6600):1471-1476

Small-molecule activation of OGG1 increases oxidative DNA damage repair by gaining a new function.

Michel M; Benítez-Buelga C; Calvo PA; Hanna BMF; Mortusewicz O; Masuyer G; Davies J; Wallner O; Sanjiv K; Albers JJ; Castañeda-Zegarra S; Jemth A-S; Visnes T; Sastre-Perona A; Danda AN; Homan EJ; Marimuthu K; Zhenjun Z; Chi CN; Sarno A; Wiita E; von Nicolai C; Komor AJ; Rajagopal V; Müller S; Hank EC; Varga M; Scaletti ER; Pandey M; Karsten S; Haslene-Hox H; Loevenich S; Marttila P; Rasti A; Mamonov K; Ortis F; Schömberg F; Loseva O; Stewart J; D'Arcy-Evans N; Koolmeister T; Henriksson M; Michel D; de Ory A; Acero L; Calvete O; Scobie M; Hertweck C; Vilotijevic I; Kalderén C; Osorio A; Perona R; Stolz A; Stenmark P; Berglund UW; de Vega M; Helleday T
Article: MOLECULAR CANCER THERAPEUTICS. 2022;21(5):703-714

Inhibition of Oxidized Nucleotide Sanitation By TH1579 and Conventional Chemotherapy Cooperatively Enhance Oxidative DNA Damage and Survival in AML.

Centio A; Estruch M; Reckzeh K; Sanjiv K; Vittori C; Engelhard S; Warpman Berglund U; Helleday T; Theilgaard-Mönch K
Article: HEPATOLOGY COMMUNICATIONS. 2022;6(5):1016-1031

MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T Cells.

Chen Y; Hua X; Huang B; Karsten S; You Z; Li B; Li Y; Li Y; Liang J; Zhang J; Wei Y; Chen R; Lyu Z; Xiao X; Lian M; Wei J; Fang J; Miao Q; Wang Q; Berglung UW; Tang R; Helleday T; Ma X
Article: NATURE CANCER. 2022;3(2):156-172

Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress.

Bonagas N; Gustafsson NMS; Henriksson M; Marttila P; Gustafsson R; Wiita E; Borhade S; Green AC; Vallin KSA; Sarno A; Svensson R; Göktürk C; Pham T; Jemth A-S; Loseva O; Cookson V; Kiweler N; Sandberg L; Rasti A; Unterlass JE; Haraldsson M; Andersson Y; Scaletti ER; Bengtsson C; Paulin CBJ; Sanjiv K; Abdurakhmanov E; Pudelko L; Kunz B; Desroses M; Iliev P; Färnegårdh K; Krämer A; Garg N; Michel M; Häggblad S; Jarvius M; Kalderén C; Jensen AB; Almlöf I; Karsten S; Zhang SM; Häggblad M; Eriksson A; Liu J; Glinghammar B; Nekhotiaeva N; Klingegård F; Koolmeister T; Martens U; Llona-Minguez S; Moulson R; Nordström H; Parrow V; Dahllund L; Sjöberg B; Vargas IL; Vo DD; Wannberg J; Knapp S; Krokan HE; Arvidsson PI; Scobie M; Meiser J; Stenmark P; Berglund UW; Homan EJ; Helleday T
Article: CELL DEATH AND DIFFERENTIATION. 2022;29(1):246-261

MTH1 as a target to alleviate T cell driven diseases by selective suppression of activated T cells.

Karsten S; Fiskesund R; Zhang X-M; Marttila P; Sanjiv K; Pham T; Rasti A; Bräutigam L; Almlöf I; Marcusson-Ståhl M; Sandman C; Platzack B; Harris RA; Kalderén C; Cederbrant K; Helleday T; Warpman Berglund U
Article: FRONTIERS IN PHARMACOLOGY. 2022;13:999180

Pharmacological OGG1 inhibition decreases murine allergic airway inflammation.

Tanner L; Bergwik J; Bhongir RKV; Pan L; Dong C; Wallner O; Kalderén C; Helleday T; Boldogh I; Adner M; Egesten A
Article: FRONTIERS IN ONCOLOGY. 2022;12:888810

OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells.

Baquero JM; Marchena-Perea E; Mirabet R; Torres-Ruiz R; Blanco-Aparicio C; Rodríguez-Perales S; Helleday T; Benítez-Buelga C; Benítez J; Osorio A
Article: CELL CHEMICAL BIOLOGY. 2021;28(12):1693-1702.e6

NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir.

Zhang SM; Rehling D; Jemth A-S; Throup A; Landázuri N; Almlöf I; Göttmann M; Valerie NCK; Borhade SR; Wakchaure P; Page BDG; Desroses M; Homan EJ; Scobie M; Rudd SG; Berglund UW; Söderberg-Nauclér C; Stenmark P; Helleday T
Article: CANCER RESEARCH. 2021;81(22):5733-5744

MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia.

Sanjiv K; Calderón-Montaño JM; Pham TM; Erkers T; Tsuber V; Almlöf I; Höglund A; Heshmati Y; Seashore-Ludlow B; Nagesh Danda A; Gad H; Wiita E; Göktürk C; Rasti A; Friedrich S; Centio A; Estruch M; Våtsveen TK; Struyf N; Visnes T; Scobie M; Koolmeister T; Henriksson M; Wallner O; Sandvall T; Lehmann S; Theilgaard-Mönch K; Garnett MJ; Östling P; Walfridsson J; Helleday T; Warpman Berglund U
Article: CELLS. 2021;10(11):3040

Adaptation to Chronic-Cycling Hypoxia Renders Cancer Cells Resistant to MTH1-Inhibitor Treatment Which Can Be Counteracted by Glutathione Depletion.

Hansel C; Hlouschek J; Xiang K; Melnikova M; Thomale J; Helleday T; Jendrossek V; Matschke J
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2021;118(36):e2007898118

Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma.

van den Boogaard ML; Oka R; Hakkert A; Schild L; Ebus ME; van Gerven MR; Zwijnenburg DA; Molenaar P; Hoyng LL; Dolman MEM; Essing AHW; Koopmans B; Helleday T; Drost J; van Boxtel R; Versteeg R; Koster J; Molenaar JJ
Article: CANCER RESEARCH. 2021;81(15):4079-4093

NEIL3 Prevents Senescence in Hepatocellular Carcinoma by Repairing Oxidative Lesions at Telomeres during Mitosis.

Zhao Z; Gad H; Benitez-Buelga C; Sanjiv K; Xiangwei H; Kang H; Feng M; Zhao Z; Berglund UW; Xia Q; Helleday T
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2021;141(8):2037-2048.e4

MTH1 Inhibitors for the Treatment of Psoriasis.

Bivik Eding C; Köhler I; Verma D; Sjögren F; Bamberg C; Karsten S; Pham T; Scobie M; Helleday T; Warpman Berglund U; Enerbäck C
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(9):4542

NEIL1 and NEIL2 Are Recruited as Potential Backup for OGG1 upon OGG1 Depletion or Inhibition by TH5487.

Hanna BMF; Michel M; Helleday T; Mortusewicz O
Article: SCIENTIFIC REPORTS. 2021;11(1):6317

Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma.

Oksvold MP; Berglund UW; Gad H; Bai B; Stokke T; Rein ID; Pham T; Sanjiv K; Øy GF; Norum JH; Smeland EB; Myklebust JH; Helleday T; Våtsveen TK
Article: SCIENTIFIC REPORTS. 2021;11(1):3490

Small molecule inhibitor of OGG1 blocks oxidative DNA damage repair at telomeres and potentiates methotrexate anticancer effects.

Baquero JM; Benítez-Buelga C; Rajagopal V; Zhenjun Z; Torres-Ruiz R; Müller S; Hanna BMF; Loseva O; Wallner O; Michel M; Rodríguez-Perales S; Gad H; Visnes T; Helleday T; Benítez J; Osorio A
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2021;296:100568

Crystal structures of NUDT15 variants enabled by a potent inhibitor reveal the structural basis for thiopurine sensitivity.

Rehling D; Zhang SM; Jemth A-S; Koolmeister T; Throup A; Wallner O; Scaletti E; Moriyama T; Nishii R; Davies J; Desroses M; Rudd SG; Scobie M; Homan E; Berglund UW; Yang JJ; Helleday T; Stenmark P
Article: VIRUSES-BASEL. 2020;13(1):E37-37

Broadly Active Antiviral Compounds Disturb Zika Virus Progeny Release Rescuing Virus-Induced Toxicity in Brain Organoids.

Pettke A; Tampere M; Pronk R; Wallner O; Falk A; Warpman Berglund U; Helleday T; Mirazimi A; Puumalainen M-R
Article: VIRUSES-BASEL. 2020;12(12):E1423-1423

Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.

Tampere M; Pettke A; Salata C; Wallner O; Koolmeister T; Cazares-Körner A; Visnes T; Hesselman MC; Kunold E; Wiita E; Kalderén C; Lightowler M; Jemth A-S; Lehtiö J; Rosenquist Å; Warpman-Berglund U; Helleday T; Mirazimi A; Jafari R; Puumalainen M-R
Article: NUCLEIC ACIDS RESEARCH. 2020;48(21):12234-12251

Targeting OGG1 arrests cancer cell proliferation by inducing replication stress.

Visnes T; Benítez-Buelga C; Cázares-Körner A; Sanjiv K; Hanna BMF; Mortusewicz O; Rajagopal V; Albers JJ; Hagey DW; Bekkhus T; Eshtad S; Baquero JM; Masuyer G; Wallner O; Müller S; Pham T; Göktürk C; Rasti A; Suman S; Torres-Ruiz R; Sarno A; Wiita E; Homan EJ; Karsten S; Marimuthu K; Michel M; Koolmeister T; Scobie M; Loseva O; Almlöf I; Unterlass JE; Pettke A; Boström J; Pandey M; Gad H; Herr P; Jemth A-S; El Andaloussi S; Kalderén C; Rodriguez-Perales S; Benítez J; Krokan HE; Altun M; Stenmark P; Berglund UW; Helleday T
Article: BIOMOLECULES. 2020;10(11):E1483-1483

OGG1 Inhibitor TH5487 Alters OGG1 Chromatin Dynamics and Prevents Incisions.

Hanna BMF; Helleday T; Mortusewicz O
Article: NATURE CHEMICAL BIOLOGY. 2020;16(10):1120-1128

Development of a chemical probe against NUDT15.

Zhang SM; Desroses M; Hagenkort A; Valerie NCK; Rehling D; Carter M; Wallner O; Koolmeister T; Throup A; Jemth A-S; Almlöf I; Loseva O; Lundbäck T; Axelsson H; Regmi S; Sarno A; Krämer A; Pudelko L; Bräutigam L; Rasti A; Göttmann M; Wiita E; Kutzner J; Schaller T; Kalderén C; Cázares-Körner A; Page BDG; Krimpenfort R; Eshtad S; Altun M; Rudd SG; Knapp S; Scobie M; Homan EJ; Berglund UW; Stenmark P; Helleday T
Article: CANCER RESEARCH. 2020;80(17):3530-3541

MTH1 Inhibitor TH588 Disturbs Mitotic Progression and Induces Mitosis-Dependent Accumulation of Genomic 8-oxodG.

Rudd SG; Gad H; Sanjiv K; Amaral N; Hagenkort A; Groth P; Ström CE; Mortusewicz O; Berglund UW; Helleday T
Article: NEOPLASIA. 2020;22(9):390-398

Ex vivo assessment of targeted therapies in a rare metastatic epithelial-myoepithelial carcinoma.

Mäkelä R; Arjonen A; Suryo Rahmanto A; Härmä V; Lehtiö J; Kuopio T; Helleday T; Sangfelt O; Kononen J; Rantala JK
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2020;295(33):11656-11668

Crystal structures of human PAICS reveal substrate and product binding of an emerging cancer target.

Škerlová J; Unterlass J; Göttmann M; Marttila P; Homan E; Helleday T; Jemth A-S; Stenmark P
Article: CELL DEATH AND DIFFERENTIATION. 2020;27(7):2081-2098

AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma.

Das I; Gad H; Bräutigam L; Pudelko L; Tuominen R; Höiom V; Almlöf I; Rajagopal V; Hansson J; Helleday T; Egyházi Brage S; Warpman Berglund U
Article: ORPHANET JOURNAL OF RARE DISEASES. 2020;15(1):170

High content drug screening for Fanconi anemia therapeutics.

Montanuy H; Camps-Fajol C; Carreras-Puigvert J; Häggblad M; Lundgren B; Aza-Carmona M; Helleday T; Minguillón J; Surrallés J
Article: CLINICAL CANCER RESEARCH. 2020;26(12):3044-3057

Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer.

Montanuy H; Martínez-Barriocanal Á; Antonio Casado J; Rovirosa L; Ramírez MJ; Nieto R; Carrascoso-Rubio C; Riera P; González A; Lerma E; Lasa A; Carreras-Puigvert J; Helleday T; Bueren JA; Arango D; Minguillón J; Surrallés J
Article: BMC MEDICAL GENOMICS. 2020;13(1):76

MetaCNV - a consensus approach to infer accurate copy numbers from low coverage data.

Friedrich S; Barbulescu R; Helleday T; Sonnhammer ELL
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2020;295(15):4761-4772

MutT homologue 1 (MTH1) removes N6-methyl-dATP from the dNTP pool.

Scaletti ER; Vallin KS; Bräutigam L; Sarno A; Warpman Berglund U; Helleday T; Stenmark P; Jemth A-S
Article: MOLECULAR & CELLULAR PROTEOMICS. 2020;19(4):608-623

Cell Cycle Profiling Reveals Protein Oscillation, Phosphorylation, and Localization Dynamics.

Herr P; Boström J; Rullman E; Rudd SG; Vesterlund M; Lehtiö J; Helleday T; Maddalo G; Altun M
Article: CANCER RESEARCH. 2020;80(7):1538-1550

Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds.

Peuget S; Zhu J; Sanz G; Singh M; Gaetani M; Chen X; Shi Y; Saei AA; Visnes T; Lindström MS; Rihani A; Moyano-Galceran L; Carlson JW; Hjerpe E; Joneborg U; Lehti K; Hartman J; Helleday T; Zubarev R; Selivanova G
Article: EMBO MOLECULAR MEDICINE. 2020;12(3):e10419

Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.

Rudd SG; Tsesmetzis N; Sanjiv K; Paulin CB; Sandhow L; Kutzner J; Hed Myrberg I; Bunten SS; Axelsson H; Zhang SM; Rasti A; Mäkelä P; Coggins SA; Tao S; Suman S; Branca RM; Mermelekas G; Wiita E; Lee S; Walfridsson J; Schinazi RF; Kim B; Lehtiö J; Rassidakis GZ; Pokrovskaja Tamm K; Warpman-Berglund U; Heyman M; Grandér D; Lehmann S; Lundbäck T; Qian H; Henter J-I; Schaller T; Helleday T; Herold N
Article: EBIOMEDICINE. 2020;53:102704

TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model.

Moukengue B; Brown HK; Charrier C; Battaglia S; Baud'huin M; Quillard T; Pham TM; Pateras IS; Gorgoulis VG; Helleday T; Heymann D; Berglund UW; Ory B; Lamoureux F
Article: JOURNAL OF MOLECULAR BIOLOGY. 2020;432(4):1126-1142

The First Structure of an Active Mammalian dCTPase and its Complexes With Substrate Analogs and Products.

Scaletti E; Claesson M; Helleday T; Jemth A-S; Stenmark P
Article: CELL DEATH AND DIFFERENTIATION. 2020;27(2):773-789

The antimalarial drug amodiaquine stabilizes p53 through ribosome biogenesis stress, independently of its autophagy-inhibitory activity.

Espinoza JA; Zisi A; Kanellis DC; Carreras-Puigvert J; Henriksson M; Hühn D; Watanabe K; Helleday T; Lindström MS; Bartek J
Article: FRONTIERS IN CHEMISTRY. 2020;8:443

In silico Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization.

Michel M; Homan EJ; Wiita E; Pedersen K; Almlöf I; Gustavsson A-L; Lundbäck T; Helleday T; Warpman Berglund U
Article: NUCLEIC ACIDS RESEARCH. 2019;47(14):7418-7429

Restriction of AID activity and somatic hypermutation by PARP-1.

Tepper S; Mortusewicz O; Członka E; Bello A; Schmidt A; Jeschke J; Fischbach A; Pfeil I; Petersen-Mahrt SK; Mangerich A; Helleday T; Leonhardt H; Jungnickel B
Article: ACS OMEGA. 2019;4(7):11642-11656

Computational and Experimental Druggability Assessment of Human DNA Glycosylases.

Michel M; Visnes T; Homan EJ; Seashore-Ludlow B; Hedenström M; Wiita E; Vallin K; Paulin CBJ; Zhang J; Wallner O; Scobie M; Schmidt A; Jenmalm-Jensen A; Warpman Berglund U; Helleday T
Article: FEBS LETTERS. 2019;593(14):1863-1873

Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugs.

Scaletti E; Jemth A-S; Helleday T; Stenmark P
Article: BIOCHEMISTRY. 2019;58(7):887-899

Crystal Structure and Substrate Specificity of the 8-oxo-dGTP Hydrolase NUDT1 from Arabidopsis thaliana.

Jemth A-S; Scaletti E; Carter M; Helleday T; Stenmark P
Article: BRITISH JOURNAL OF PHARMACOLOGY. 2019;176(3):436-450

Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeutics.

Lallo A; Gulati S; Schenk MW; Khandelwal G; Berglund UW; Pateras IS; Chester CPE; Pham TM; Kalderen C; Frese KK; Gorgoulis VG; Miller C; Blackhall F; Helleday T; Dive C
Article: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2019;11:1758835919866960-175883591986696

Karonudib is a promising anticancer therapy in hepatocellular carcinoma.

Hua X; Sanjiv K; Gad H; Pham T; Gokturk C; Rasti A; Zhao Z; He K; Feng M; Zang Y; Zhang J; Xia Q; Helleday T; Warpman Berglund U
Article: SCIENCE. 2018;362(6416):834-839

Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation.

Visnes T; Cázares-Körner A; Hao W; Wallner O; Masuyer G; Loseva O; Mortusewicz O; Wiita E; Sarno A; Manoilov A; Astorga-Wells J; Jemth A-S; Pan L; Sanjiv K; Karsten S; Gokturk C; Grube M; Homan EJ; Hanna BMF; Paulin CBJ; Pham T; Rasti A; Berglund UW; von Nicolai C; Benitez-Buelga C; Koolmeister T; Ivanic D; Iliev P; Scobie M; Krokan HE; Baranczewski P; Artursson P; Altun M; Jensen AJ; Kalderén C; Ba X; Zubarev RA; Stenmark P; Boldogh I; Helleday T
Article: NUCLEIC ACIDS RESEARCH. 2018;46(20):10888-10904

MutT homologue 1 (MTH1) catalyzes the hydrolysis of mutagenic O6-methyl-dGTP.

Jemth A-S; Gustafsson R; Bräutigam L; Henriksson L; Vallin KSA; Sarno A; Almlöf I; Homan E; Rasti A; Warpman Berglund U; Stenmark P; Helleday T
Article: DNA REPAIR. 2018;71:118-126

Targeting BER enzymes in cancer therapy.

Visnes T; Grube M; Hanna BMF; Benitez-Buelga C; Cázares-Körner A; Helleday T
Article: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2018;160:80-88

STAT3 differential scanning fluorimetry and differential scanning light scattering assays: Addressing a missing link in the characterization of STAT3 inhibitor interactions.

Desroses M; Busker S; Astorga-Wells J; Attarha S; Kolosenko I; Zubarev RA; Helleday T; Grandér D; Page BDG
Article: ONCOTARGET. 2018;9(80):35069-35084

The Cockayne syndrome protein B is involved in the repair of 5-AZA-2'-deoxycytidine-induced DNA lesions.

Burgos-Morón E; Calderón-Montaño JM; Pastor N; Höglund A; Ruiz-Castizo Á; Domínguez I; López-Lázaro M; Hajji N; Helleday T; Mateos S; Orta ML
Article: NEURO-ONCOLOGY. 2018;20(11):1475-1484

An orthotopic glioblastoma animal model suitable for high-throughput screenings.

Pudelko L; Edwards S; Balan M; Nyqvist D; Al-Saadi J; Dittmer J; Almlöf I; Helleday T; Bräutigam L
Article: NATURE COMMUNICATIONS. 2018;9(1):3872

Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination.

Gustafsson NMS; Färnegårdh K; Bonagas N; Ninou AH; Groth P; Wiita E; Jönsson M; Hallberg K; Lehto J; Pennisi R; Martinsson J; Norström C; Hollers J; Schultz J; Andersson M; Markova N; Marttila P; Kim B; Norin M; Olin T; Helleday T
Article: HUMAN MUTATION. 2018;39(9):1214-1225

Germline variation in the oxidative DNA repair genes NUDT1 and OGG1 is not associated with hereditary colorectal cancer or polyposis.

Mur P; Jemth A-S; Bevc L; Amaral N; Navarro M; Valdés-Mas R; Pons T; Aiza G; Urioste M; Valencia A; Lázaro C; Moreno V; Puente XS; Stenmark P; Warpman-Berglund U; Capellá G; Helleday T; Valle L
Article: CELL DEATH & DISEASE. 2018;9(8):810

A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma.

Einarsdottir BO; Karlsson J; Söderberg EMV; Lindberg MF; Funck-Brentano E; Jespersen H; Brynjolfsson SF; Olofsson Bagge R; Carstam L; Scobie M; Koolmeister T; Wallner O; Stierner U; Berglund UW; Ny L; Nilsson LM; Larsson E; Helleday T; Nilsson JA
Article: RSC MEDICINAL CHEMISTRY. 2018;9(7):1105-1113

A synthetic diphosphoinositol phosphate analogue of inositol trisphosphate.

Riley AM; Unterlass J; Konieczny V; Taylor CW; Helleday T; Potter BVL
Article: NATURE COMMUNICATIONS. 2018;9(1):2419

Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity.

Berglund E; Maaskola J; Schultz N; Friedrich S; Marklund M; Bergenstråhle J; Tarish F; Tanoglidi A; Vickovic S; Larsson L; Salmén F; Ogris C; Wallenborg K; Lagergren J; Ståhl P; Sonnhammer E; Helleday T; Lundeberg J
Article: CELL CYCLE. 2018;17(5):568-579

Distinct mechanistic responses to replication fork stalling induced by either nucleotide or protein deprivation.

Henriksson S; Groth P; Gustafsson N; Helleday T
Article: STRUCTURE. 2018;26(2):295-303.e6

Human NUDT22 Is a UDP-Glucose/Galactose Hydrolase Exhibiting a Unique Structural Fold.

Carter M; Jemth A-S; Carreras-Puigvert J; Herr P; Martínez Carranza M; Vallin KSA; Throup A; Helleday T; Stenmark P
Article: BIOCHEMISTRY. 2018;57(5):593-603

Crystal Structures and Inhibitor Interactions of Mouse and Dog MTH1 Reveal Species-Specific Differences in Affinity.

Narwal M; Jemth A-S; Gustafsson R; Almlöf I; Warpman Berglund U; Helleday T; Stenmark P
Article: ACTA ONCOLOGICA. 2018;57(2):187-194

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Glimelius B; Melin B; Enblad G; Alafuzoff I; Beskow A; Ahlström H; Bill-Axelson A; Birgisson H; Björ O; Edqvist P-H; Hansson T; Helleday T; Hellman P; Henriksson K; Hesselager G; Hultdin M; Häggman M; Höglund M; Jonsson H; Larsson C; Lindman H; Ljuslinder I; Mindus S; Nygren P; Pontén F; Riklund K; Rosenquist R; Sandin F; Schwenk JM; Stenling R; Stålberg K; Stålberg P; Sundström C; Thellenberg Karlsson C; Westermark B; Bergh A; Claesson-Welsh L; Palmqvist R; Sjöblom T
Article: NATURE COMMUNICATIONS. 2018;9(1):250

Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.

Page BDG; Valerie NCK; Wright RHG; Wallner O; Isaksson R; Carter M; Rudd SG; Loseva O; Jemth A-S; Almlöf I; Font-Mateu J; Llona-Minguez S; Baranczewski P; Jeppsson F; Homan E; Almqvist H; Axelsson H; Regmi S; Gustavsson A-L; Lundbäck T; Scobie M; Strömberg K; Stenmark P; Beato M; Helleday T
Article: PLOS ONE. 2018;13(1):e0191231

Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer.

Thålin C; Lundström S; Seignez C; Daleskog M; Lundström A; Henriksson P; Helleday T; Phillipson M; Wallén H; Demers M
Article: NATURE COMMUNICATIONS. 2017;8(1):1541

A comprehensive structural, biochemical and biological profiling of the human NUDIX hydrolase family.

Carreras-Puigvert J; Zitnik M; Jemth A-S; Carter M; Unterlass JE; Hallström B; Loseva O; Karem Z; Calderón-Montaño JM; Lindskog C; Edqvist P-H; Matuszewski DJ; Ait Blal H; Berntsson RPA; Häggblad M; Martens U; Studham M; Lundgren B; Wählby C; Sonnhammer ELL; Lundberg E; Stenmark P; Zupan B; Helleday T
Article: ONCOTARGET. 2017;8(49):84671-84684

Glioblastoma and glioblastoma stem cells are dependent on functional MTH1.

Pudelko L; Rouhi P; Sanjiv K; Gad H; Kalderén C; Höglund A; Squatrito M; Schuhmacher AJ; Edwards S; Hägerstrand D; Berglund UW; Helleday T; Bräutigam L
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2017;60(19):8160-8169

Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space.

Rudling A; Gustafsson R; Almlöf I; Homan E; Scobie M; Warpman Berglund U; Helleday T; Stenmark P; Carlsson J
Article: ORGANIC & BIOMOLECULAR CHEMISTRY. 2017;15(37):7758-7764

Novel spirocyclic systems via multicomponent aza-Diels-Alder reaction.

Llona-Minguez S; Throup A; Steiner E; Lightowler M; Van der Haegen S; Homan E; Eriksson L; Stenmark P; Jenmalm-Jensen A; Helleday T
Article: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 2017;27(18):4462-4466

Tetrahydrobenzothiophene carboxamides: Beyond the kinase domain and into the fatty acid realm.

Llona-Minguez S; Fayezi S; Alihemmati A; Juárez-Jiménez J; Piedrafita FJ; Helleday T
Article: DNA REPAIR. 2017;57:116-124

Zebularine induces replication-dependent double-strand breaks which are preferentially repaired by homologous recombination.

Orta ML; Pastor N; Burgos-Morón E; Domínguez I; Calderón-Montaño JM; Huertas Castaño C; López-Lázaro M; Helleday T; Mateos S
Article: NATURE COMMUNICATIONS. 2017;8(1):374

Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer.

Asim M; Tarish F; Zecchini HI; Sanjiv K; Gelali E; Massie CE; Baridi A; Warren AY; Zhao W; Ogris C; McDuffus L-A; Mascalchi P; Shaw G; Dev H; Wadhwa K; Wijnhoven P; Forment JV; Lyons SR; Lynch AG; O'Neill C; Zecchini VR; Rennie PS; Baniahmad A; Tavaré S; Mills IG; Galanty Y; Crosetto N; Schultz N; Neal D; Helleday T
Article: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 2017;27(16):3897-3904

Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 1: Triazoles, triazolopyrimidines, triazinoindoles, quinoline hydrazones and arylpiperazines.

Llona-Minguez S; Häggblad M; Martens U; Throup A; Loseva O; Jemth A-S; Lundgren B; Scobie M; Helleday T
Article: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 2017;27(15):3219-3225

Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 2: Pyridone- and pyrimidinone-derived systems.

Llona-Minguez S; Häggblad M; Martens U; Johansson L; Sigmundsson K; Lundbäck T; Loseva O; Jemth A-S; Lundgren B; Jensen AJ; Scobie M; Helleday T
Article: EXPERIMENTAL HEMATOLOGY. 2017;52:32-39

With me or against me: Tumor suppressor and drug resistance activities of SAMHD1.

Herold N; Rudd SG; Sanjiv K; Kutzner J; Myrberg IH; Paulin CBJ; Olsen TK; Helleday T; Henter J-I; Schaller T
Article: EMBO JOURNAL. 2017;36(14):2161-2176

ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration.

Jaiswal H; Benada J; Müllers E; Akopyan K; Burdova K; Koolmeister T; Helleday T; Medema RH; Macurek L; Lindqvist A
Article: BIOMOLECULES. 2017;7(3):E49-49

Mutations in Cancer Cause Gain of Cysteine, Histidine, and Tryptophan at the Expense of a Net Loss of Arginine on the Proteome Level.

Tsuber V; Kadamov Y; Brautigam L; Berglund UW; Helleday T
Article: RSC MEDICINAL CHEMISTRY. 2017;8(7):1553-1560

Structure-metabolism-relationships in the microsomal clearance of piperazin-1-ylpyridazines.

Llona-Minguez S; Ghassemian A; Baranczewski P; Desroses M; Koolmeister T; Artursson P; Scobie M; Helleday T
Article: CELL CYCLE. 2017;16(11):1029-1038

SAMHD1 protects cancer cells from various nucleoside-based antimetabolites.

Herold N; Rudd SG; Sanjiv K; Kutzner J; Bladh J; Paulin CBJ; Helleday T; Henter J-I; Schaller T
Article: NATURE CHEMICAL BIOLOGY. 2017;13(6):681-690

Global survey of the immunomodulatory potential of common drugs.

Vladimer GI; Snijder B; Krall N; Bigenzahn JW; Huber KVM; Lardeau C-H; Sanjiv K; Ringler A; Berglund UW; Sabler M; de la Fuente OL; Knöbl P; Kubicek S; Helleday T; Jäger U; Superti-Furga G
Article: IMMUNOLOGIC RESEARCH. 2017;65(3):706-712

Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma.

Thålin C; Daleskog M; Göransson SP; Schatzberg D; Lasselin J; Laska A-C; Kallner A; Helleday T; Wallén H; Demers M
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2017;60(10):4279-4292

Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors.

Llona-Minguez S; Höglund A; Ghassemian A; Desroses M; Calderón-Montaño JM; Burgos Morón E; Valerie NCK; Wiita E; Almlöf I; Koolmeister T; Mateus A; Cazares-Körner C; Sanjiv K; Homan E; Loseva O; Baranczewski P; Darabi M; Mehdizadeh A; Fayezi S; Jemth A-S; Warpman Berglund U; Sigmundsson K; Lundbäck T; Jenmalm Jensen A; Artursson P; Scobie M; Helleday T
Article: ONCOTARGET. 2017;8(14):23713-23726

dUTPase inhibition augments replication defects of 5-Fluorouracil.

Hagenkort A; Paulin CBJ; Desroses M; Sarno A; Wiita E; Mortusewicz O; Koolmeister T; Loseva O; Jemth A-S; Almlöf I; Homan E; Lundbäck T; Gustavsson A-L; Scobie M; Helleday T
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2017;60(5):2148-2154

Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1.

Llona-Minguez S; Höglund A; Wiita E; Almlöf I; Mateus A; Calderón-Montaño JM; Cazares-Körner C; Homan E; Loseva O; Baranczewski P; Jemth A-S; Häggblad M; Martens U; Lundgren B; Artursson P; Lundbäck T; Jenmalm Jensen A; Warpman Berglund U; Scobie M; Helleday T
Article: CANCER RESEARCH. 2017;77(4):937-948

Crystal Structure of the Emerging Cancer Target MTHFD2 in Complex with a Substrate-Based Inhibitor.

Gustafsson R; Jemth A-S; Gustafsson NMS; Färnegårdh K; Loseva O; Wiita E; Bonagas N; Dahllund L; Llona-Minguez S; Häggblad M; Henriksson M; Andersson Y; Homan E; Helleday T; Stenmark P
Article: NATURE MEDICINE. 2017;23(2):256-263

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.

Herold N; Rudd SG; Ljungblad L; Sanjiv K; Myrberg IH; Paulin CBJ; Heshmati Y; Hagenkort A; Kutzner J; Page BDG; Calderón-Montaño JM; Loseva O; Jemth A-S; Bulli L; Axelsson H; Tesi B; Valerie NCK; Höglund A; Bladh J; Wiita E; Sundin M; Uhlin M; Rassidakis G; Heyman M; Tamm KP; Warpman-Berglund U; Walfridsson J; Lehmann S; Grandér D; Lundbäck T; Kogner P; Henter J-I; Helleday T; Schaller T
Article: NUCLEIC ACIDS RESEARCH. 2017;45(2):e8

A novel method for crosstalk analysis of biological networks: improving accuracy of pathway annotation.

Ogris C; Guala D; Helleday T; Sonnhammer ELL
Article: CELL CYCLE. 2017;16(2):189-199

Genome-wide screen of cell-cycle regulators in normal and tumor cells identifies a differential response to nucleosome depletion.

Sokolova M; Turunen M; Mortusewicz O; Kivioja T; Herr P; Vähärautio A; Björklund M; Taipale M; Helleday T; Taipale J
Article: PLOS ONE. 2017;12(6):e0178844

Identification of novel small molecules that inhibit STAT3-dependent transcription and function.

Kolosenko I; Yu Y; Busker S; Dyczynski M; Liu J; Haraldsson M; Palm Apergi C; Helleday T; Tamm KP; Page BDG; Grander D
Article: ONCOGENESIS. 2016;5(12):e280

The spliceosome U2 snRNP factors promote genome stability through distinct mechanisms; transcription of repair factors and R-loop processing.

Tanikawa M; Sanjiv K; Helleday T; Herr P; Mortusewicz O
Article: ONCOGENESIS. 2016;5(12):e275

hMYH and hMTH1 cooperate for survival in mismatch repair defective T-cell acute lymphoblastic leukemia.

Eshtad S; Mavajian Z; Rudd SG; Visnes T; Boström J; Altun M; Helleday T
Article: ANNALS OF ONCOLOGY. 2016;27(12):2275-2283

Validation and development of MTH1 inhibitors for treatment of cancer.

Warpman Berglund U; Sanjiv K; Gad H; Kalderén C; Koolmeister T; Pham T; Gokturk C; Jafari R; Maddalo G; Seashore-Ludlow B; Chernobrovkin A; Manoilov A; Pateras IS; Rasti A; Jemth A-S; Almlöf I; Loseva O; Visnes T; Einarsdottir BO; Gaugaz FZ; Saleh A; Platzack B; Wallner OA; Vallin KSA; Henriksson M; Wakchaure P; Borhade S; Herr P; Kallberg Y; Baranczewski P; Homan EJ; Wiita E; Nagpal V; Meijer T; Schipper N; Rudd SG; Bräutigam L; Lindqvist A; Filppula A; Lee T-C; Artursson P; Nilsson JA; Gorgoulis VG; Lehtiö J; Zubarev RA; Scobie M; Helleday T
Article: CANCER RESEARCH. 2016;76(18):5501-5511

NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine.

Valerie NCK; Hagenkort A; Page BDG; Masuyer G; Rehling D; Carter M; Bevc L; Herr P; Homan E; Sheppard NG; Stenmark P; Jemth A-S; Helleday T
Article: NUCLEIC ACIDS RESEARCH. 2016;44(W1):W105-W109

PathwAX: a web server for network crosstalk based pathway annotation.

Ogris C; Helleday T; Sonnhammer ELL
Article: CELL DEATH & DISEASE. 2016;7(6):e2267

Overexpression of the scaffold WD40 protein WRAP53β enhances the repair of and cell survival from DNA double-strand breaks.

Rassoolzadeh H; Böhm S; Hedström E; Gad H; Helleday T; Henriksson S; Farnebo M
Article: CANCER RESEARCH. 2016;76(8):2366-2375

Hypoxic Signaling and the Cellular Redox Tumor Environment Determine Sensitivity to MTH1 Inhibition.

Bräutigam L; Pudelko L; Jemth A-S; Gad H; Narwal M; Gustafsson R; Karsten S; Carreras Puigvert J; Homan E; Berndt C; Berglund UW; Stenmark P; Helleday T
Article: CANCER RESEARCH. 2016;76(5):1078-1088

DNA-PKcs and PARP1 Bind to Unresected Stalled DNA Replication Forks Where They Recruit XRCC1 to Mediate Repair.

Ying S; Chen Z; Medhurst AL; Neal JA; Bao Z; Mortusewicz O; McGouran J; Song X; Shen H; Hamdy FC; Kessler BM; Meek K; Helleday T
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2016;59(3):1140-1148

Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1.

Llona-Minguez S; Höglund A; Jacques SA; Johansson L; Calderón-Montaño JM; Claesson M; Loseva O; Valerie NCK; Lundbäck T; Piedrafita J; Maga G; Crespan E; Meijer L; Morón EB; Baranczewski P; Hagbjörk A-L; Svensson R; Wiita E; Almlöf I; Visnes T; Jeppsson F; Sigmundsson K; Jensen AJ; Artursson P; Jemth A-S; Stenmark P; Berglund UW; Scobie M; Helleday T
Article: ONCOGENE. 2016;35(6):761-770

PC4 promotes genome stability and DNA repair through binding of ssDNA at DNA damage sites.

Mortusewicz O; Evers B; Helleday T
Article: CELL REPORTS. 2016;14(2):298-309

Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities.

Sanjiv K; Hagenkort A; Calderón-Montaño JM; Koolmeister T; Reaper PM; Mortusewicz O; Jacques SA; Kuiper RV; Schultz N; Scobie M; Charlton PA; Pollard JR; Berglund UW; Altun M; Helleday T
Article: ONCOTARGET. 2015;6(35):37638-37646

Acute MUS81 depletion leads to replication fork slowing and a constitutive DNA damage response.

Xing M; Wang X; Palmai-Pallag T; Shen H; Helleday T; Hickson ID; Ying S
Article: SCIENCE TRANSLATIONAL MEDICINE. 2015;7(312):312re11

Castration radiosensitizes prostate cancer tissue by impairing DNA double-strand break repair.

Tarish FL; Schultz N; Tanoglidi A; Hamberg H; Letocha H; Karaszi K; Hamdy FC; Granfors T; Helleday T
Article: MOLECULAR CELL. 2015;60(1):163-176

Timeless Interacts with PARP-1 to Promote Homologous Recombination Repair.

Xie S; Mortusewicz O; Ma HT; Herr P; Poon RYC; Helleday T; Qian C
Article: MOLECULAR CELL. 2015;59(6):984-997

PARP1- and CTCF-Mediated Interactions between Active and Repressed Chromatin at the Lamina Promote Oscillating Transcription.

Zhao H; Sifakis EG; Sumida N; Millán-Ariño L; Scholz BA; Svensson JP; Chen X; Ronnegren AL; Mallet de Lima CD; Varnoosfaderani FS; Shi C; Loseva O; Yammine S; Israelsson M; Rathje L-S; Németi B; Fredlund E; Helleday T; Imreh MP; Göndör A
Article: DNA REPAIR. 2015;33:101-110

Addiction to MTH1 protein results in intense expression in human breast cancer tissue as measured by liquid chromatography-isotope-dilution tandem mass spectrometry.

Coskun E; Jaruga P; Jemth A-S; Loseva O; Scanlan LD; Tona A; Lowenthal MS; Helleday T; Dizdaroglu M
Article: NATURE COMMUNICATIONS. 2015;6:7871

Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2.

Carter M; Jemth A-S; Hagenkort A; Page BDG; Gustafsson R; Griese JJ; Gad H; Valerie NCK; Desroses M; Boström J; Warpman Berglund U; Helleday T; Stenmark P
Article: BIOCHEMICAL JOURNAL. 2015;468(2):293-301

Processing of protein ADP-ribosylation by Nudix hydrolases.

Palazzo L; Thomas B; Jemth A-S; Colby T; Leidecker O; Feijs KLH; Zaja R; Loseva O; Puigvert JC; Matic I; Helleday T; Ahel I
Article: CHEMISTRY-A EUROPEAN JOURNAL. 2015;21(20):7394-7398

Vinylic MIDA Boronates: New Building Blocks for the Synthesis of Aza-Heterocycles.

Llona-Minguez S; Desroses M; Ghassemian A; Jacques SA; Eriksson L; Isacksson R; Koolmeister T; Stenmark P; Scobie M; Helleday T
Article: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2015;104:1-11

Development and validation of method for TH588 and TH287, potent MTH1 inhibitors and new anti-cancer agents, for pharmacokinetic studies in mice plasma.

Saleh A; Gökturk C; Warpman-Berglund U; Helleday T; Granelli I
Article: CELL DISCOVERY. 2015;1:15034

A genome-wide IR-induced RAD51 foci RNAi screen identifies CDC73 involved in chromatin remodeling for DNA repair.

Herr P; Lundin C; Evers B; Ebner D; Bauerschmidt C; Kingham G; Palmai-Pallag T; Mortusewicz O; Frings O; Sonnhammer E; Helleday T
Article: GENES & DEVELOPMENT. 2014;28(24):2726-2738

The scaffold protein WRAP53β orchestrates the ubiquitin response critical for DNA double-strand break repair.

Henriksson S; Rassoolzadeh H; Hedström E; Coucoravas C; Julner A; Goldstein M; Imreh G; Zhivotovsky B; Kastan MB; Helleday T; Farnebo M
Article: NUCLEIC ACIDS RESEARCH. 2014;42(14):9108-9120

The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2'-deoxycytidine lesions.

Orta ML; Höglund A; Calderón-Montaño JM; Domínguez I; Burgos-Morón E; Visnes T; Pastor N; Ström C; López-lázaro M; Helleday T
Article: PROTEOMES. 2014;2(3):341-362

Chronic Low Dose Rate Ionizing Radiation Exposure Induces Premature Senescence in Human Fibroblasts that Correlates with Up Regulation of Proteins Involved in Protection against Oxidative Stress.

Loseva O; Shubbar E; Haghdoost S; Evers B; Helleday T; Harms-Ringdahl M
Article: CELL REPORTS. 2014;7(6):2006-2018

SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability.

Pfister SX; Ahrabi S; Zalmas L-P; Sarkar S; Aymard F; Bachrati CZ; Helleday T; Legube G; La Thangue NB; Porter ACG; Humphrey TC
Article: SCIENTIFIC REPORTS. 2014;4:5372

Rational design and validation of a Tip60 histone acetyltransferase inhibitor.

Gao C; Bourke E; Scobie M; Famme MA; Koolmeister T; Helleday T; Eriksson LA; Lowndes NF; Brown JAL
Article: NUCLEIC ACIDS RESEARCH. 2014;42(10):6326-6336

Human single-stranded DNA binding protein 1 (hSSB1/NABP2) is required for the stability and repair of stalled replication forks.

Bolderson E; Petermann E; Croft L; Suraweera A; Pandita RK; Pandita TK; Helleday T; Khanna KK; Richard DJ
Article: NATURE. 2014;508(7495):222-227

Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy.

Huber KVM; Salah E; Radic B; Gridling M; Elkins JM; Stukalov A; Jemth A-S; Göktürk C; Sanjiv K; Strömberg K; Pham T; Berglund UW; Colinge J; Bennett KL; Loizou JI; Helleday T; Knapp S; Superti-Furga G
Article: NATURE. 2014;508(7495):215-221

MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.

Gad H; Koolmeister T; Jemth A-S; Eshtad S; Jacques SA; Ström CE; Svensson LM; Schultz N; Lundbäck T; Einarsdottir BO; Saleh A; Göktürk C; Baranczewski P; Svensson R; Berntsson RP-A; Gustafsson R; Strömberg K; Sanjiv K; Jacques-Cordonnier M-C; Desroses M; Gustavsson A-L; Olofsson R; Johansson F; Homan EJ; Loseva O; Bräutigam L; Johansson L; Höglund A; Hagenkort A; Pham T; Altun M; Gaugaz FZ; Vikingsson S; Evers B; Henriksson M; Vallin KSA; Wallner OA; Hammarström LGJ; Wiita E; Almlöf I; Kalderén C; Axelsson H; Djureinovic T; Puigvert JC; Häggblad M; Jeppsson F; Martens U; Lundin C; Lundgren B; Granelli I; Jensen AJ; Artursson P; Nilsson JA; Stenmark P; Scobie M; Berglund UW; Helleday T
Article: SCIENCE. 2014;343(6166):88-91

Break-induced replication repair of damaged forks induces genomic duplications in human cells.

Costantino L; Sotiriou SK; Rantala JK; Magin S; Mladenov E; Helleday T; Haber JE; Iliakis G; Kallioniemi OP; Halazonetis TD
Article: CELL CYCLE. 2013;12(24):3770-3780

SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways.

Gubanova E; Issaeva N; Gokturk C; Djureinovic T; Helleday T
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2013;110(42):16856-16861

Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity.

Köpper F; Bierwirth C; Schön M; Kunze M; Elvers I; Kranz D; Saini P; Menon MB; Walter D; Sørensen CS; Gaestel M; Helleday T; Schön MP; Dobbelstein M
Article: CELL CYCLE. 2013;12(18):3037-3051

E2F-7 couples DNA damage-dependent transcription with the DNA repair process.

Zalmas L-P; Coutts AS; Helleday T; La Thangue NB
Article: EUROPEAN JOURNAL OF ORGANIC CHEMISTRY. 2013;2013(26):5879-5885

A Convenient Microwave-Assisted Propylphosphonic Anhydride (T3P^®) Mediated One-Pot Pyrazolone Synthesis

Desroses M; Jacques-Cordonnier M-C; Llona-Minguez S; Jacques S; Koolmeister T; Helleday T; Scobie M
Article: ONCOGENE. 2013;32(32):3744-3753

Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress.

Jones RM; Mortusewicz O; Afzal I; Lorvellec M; García P; Helleday T; Petermann E
Article: RADIOTHERAPY AND ONCOLOGY. 2013;108(1):155-161

Homologous recombination mediates cellular resistance and fraction size sensitivity to radiation therapy.

Somaiah N; Yarnold J; Lagerqvist A; Rothkamm K; Helleday T
Article: TETRAHEDRON LETTERS. 2013;54(27):3554-3557

A facile and efficient synthesis of tetrahydro-β-carbolines

Desroses M; Koolmeister T; Jacques S; Llona-Minguez S; Jacques-Cordonnier M-C; Cazares-Korner A; Helleday T; Scobie M
Article: NUCLEIC ACIDS RESEARCH. 2013;41(11):5827-5836

5-Aza-2'-deoxycytidine causes replication lesions that require Fanconi anemia-dependent homologous recombination for repair.

Orta ML; Calderón-Montaño JM; Domínguez I; Pastor N; Burgos-Morón E; López-Lázaro M; Cortés F; Mateos S; Helleday T
Article: CLINICAL CANCER RESEARCH. 2013;19(6):1547-1556

Castration therapy results in decreased Ku70 levels in prostate cancer.

Al-Ubaidi FLT; Schultz N; Loseva O; Egevad L; Granfors T; Helleday T
Article: NATURE. 2013;494(7438):492-496

Replication stress links structural and numerical cancer chromosomal instability.

Burrell RA; McClelland SE; Endesfelder D; Groth P; Weller M-C; Shaikh N; Domingo E; Kanu N; Dewhurst SM; Gronroos E; Chew SK; Rowan AJ; Schenk A; Sheffer M; Howell M; Kschischo M; Behrens A; Helleday T; Bartek J; Tomlinson IP; Swanton C
Article: CARCINOGENESIS. 2013;34(2):325-330

Genotoxicity of alcohol is linked to DNA replication-associated damage and homologous recombination repair.

Kotova N; Vare D; Schultz N; Gradecka Meesters D; Stepnik M; Grawé J; Helleday T; Jenssen D
Article: NEW JOURNAL OF CHEMISTRY. 2013;37(11):3595-3597

A new concise synthesis of 2,3-dihydroquinazolin-4(1H)-one derivatives

Desroses M; Scobie M; Helleday T
Article: CARCINOGENESIS. 2013;34(1):139-145

DNA damage response in peritumoral regions of oesophageal cancer microenvironment.

He H; Tian D; Guo J; Liu M; Chen Z; Hamdy FC; Helleday T; Su M; Ying S
Article: BIOMOLECULES. 2012;2(4):635-649

Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy.

Ström CE; Helleday T
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2012;287(50):42206-42222

Targeting protein for xenopus kinesin-like protein 2 (TPX2) regulates γ-histone 2AX (γ-H2AX) levels upon ionizing radiation.

Neumayer G; Helfricht A; Shim SY; Le HT; Lundin C; Belzil C; Chansard M; Yu Y; Lees-Miller SP; Gruss OJ; van Attikum H; Helleday T; Nguyen MD
Article: CARCINOGENESIS. 2012;33(11):2026-2034

Homologous recombination mediates S-phase-dependent radioresistance in cells deficient in DNA polymerase eta.

Nicolay NH; Carter R; Hatch SB; Schultz N; Prevo R; McKenna WG; Helleday T; Sharma RA
Article: CLINICAL CANCER RESEARCH. 2012;18(19):5479-5488

The relationship between homologous recombination repair and the sensitivity of human epidermis to the size of daily doses over a 5-week course of breast radiotherapy.

Somaiah N; Yarnold J; Daley F; Pearson A; Gothard L; Rothkamm K; Helleday T
Article: NUCLEIC ACIDS RESEARCH. 2012;40(17):8440-8448

CHK1 activity is required for continuous replication fork elongation but not stabilization of post-replicative gaps after UV irradiation.

Elvers I; Hagenkort A; Johansson F; Djureinovic T; Lagerqvist A; Schultz N; Stoimenov I; Erixon K; Helleday T
Article: NUCLEIC ACIDS RESEARCH. 2012;40(14):6585-6594

Homologous recombination repairs secondary replication induced DNA double-strand breaks after ionizing radiation.

Groth P; Orta ML; Elvers I; Majumder MM; Lagerqvist A; Helleday T
Article: BIOCHEMICAL PHARMACOLOGY. 2012;83(11):1514-1522

Minor structural modifications to alchemix influence mechanism of action and pharmacological activity.

Abdallah QMA; Phillips RM; Johansson F; Helleday T; Cosentino L; Abdel-Rahman H; Etzad J; Wheelhouse RT; Kiakos K; Bingham JP; Hartley JA; Patterson LH; Pors K
Article: CANCER RESEARCH. 2012;72(11):2814-2821

Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1.

Ying S; Hamdy FC; Helleday T
Article: LIPIDS. 2012;47(4):355-361

N-acyl taurines are anti-proliferative in prostate cancer cells.

Chatzakos V; Slätis K; Djureinovic T; Helleday T; Hunt MC
Article: ENVIRONMENTAL AND MOLECULAR MUTAGENESIS. 2012;53(2):114-124

Uncoupling of RAD51 focus formation and cell survival after replication fork stalling in RAD51D null CHO cells.

Urbin SS; Elvers I; Hinz JM; Helleday T; Thompson LH
Article: CLINICAL CANCER RESEARCH. 2012;18(5):1257-1267

Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.

Gubanova E; Brown B; Ivanov SV; Helleday T; Mills GB; Yarbrough WG; Issaeva N
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2012;82(3):1243-1248

Castration therapy of prostate cancer results in downregulation of HIF-1α levels.

Al-Ubaidi FLT; Schultz N; Egevad L; Granfors T; Helleday T
Article: CLINICAL CANCER RESEARCH. 2012;18(4):1015-1027

PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy.

Fraser M; Zhao H; Luoto KR; Lundin C; Coackley C; Chan N; Joshua AM; Bismar TA; Evans A; Helleday T; Bristow RG
Article: MOLECULAR CANCER THERAPEUTICS. 2012;11(1):98-107

Targeted mutations in the ATR pathway define agent-specific requirements for cancer cell growth and survival.

Wilsker D; Chung JH; Pradilla I; Petermann E; Helleday T; Bunz F
Article: DNA REPAIR. 2011;10(9):961-969

CK2 phosphorylation of XRCC1 facilitates dissociation from DNA and single-strand break formation during base excision repair.

Ström CE; Mortusewicz O; Finch D; Parsons JL; Lagerqvist A; Johansson F; Schultz N; Erixon K; Dianov GL; Helleday T
Article: EUROPEAN JOURNAL OF CANCER. 2011;47 Suppl 3:S333-S335

DNA repair as treatment target.

Helleday T
Article: NUCLEIC ACIDS RESEARCH. 2011;39(16):7049-7057

UV stalled replication forks restart by re-priming in human fibroblasts.

Elvers I; Johansson F; Groth P; Erixon K; Helleday T
Article: FEBS LETTERS. 2011;585(16):2617-2621

Crystal structure of human MTH1 and the 8-oxo-dGMP product complex.

Svensson LM; Jemth A-S; Desroses M; Loseva O; Helleday T; Högbom M; Stenmark P
Article: RADIATION RESEARCH. 2011

Radiation Resistance in Cancer Therapy: Meeting Summary and Research Opportunities: Report of an NCI Workshop held September 1-3, 2010.

Glazer PM; Grandis J; Powell SN; Brown JM; Helleday T; Bristow R; Powis G; Hill RP; Le Q-T; Pelroy R; Mohla S; Bernhard EJ
Article: RADIATION RESEARCH. 2011;176(3):e0016-e0021

Radiation Resistance in Cancer Therapy: meeting summary and research opportunities. Report of an NCI Workshop held September 1-3, 2010.

Glazer PM; Grandis J; Powell SN; Brown JM; Helleday T; Bristow R; Powis G; Hill RP; Le Q-T; Pelroy R; Mohla S; Bernhard EJ; NCI Workshop Participants
Article: EMBO REPORTS. 2011;12(7):713-719

ATM-mediated phosphorylation of polynucleotide kinase/phosphatase is required for effective DNA double-strand break repair.

Segal-Raz H; Mass G; Baranes-Bachar K; Lerenthal Y; Wang S-Y; Chung YM; Ziv-Lehrman S; Ström CE; Helleday T; Hu MC-T; Chen DJ; Shiloh Y
Article: CANCER BIOLOGY & THERAPY. 2011;11(12):1028-1035

Breast cancer stem-like cells show dominant homologous recombination due to a larger S-G2 fraction.

Al-Assar O; Mantoni T; Lunardi S; Kingham G; Helleday T; Brunner TB
Article: PLOS ONE. 2011;6(5):e19659

FANCD1/BRCA2 plays predominant role in the repair of DNA damage induced by ACNU or TMZ.

Kondo N; Takahashi A; Mori E; Noda T; Zdzienicka MZ; Thompson LH; Helleday T; Suzuki M; Kinashi Y; Masunaga S; Ono K; Hasegawa M; Ohnishi T
Article: PLOS ONE. 2011;6(5):e19492

Transcription inhibition by DRB potentiates recombinational repair of UV lesions in mammalian cells.

Stoimenov I; Schultz N; Gottipati P; Helleday T
Article: NUCLEIC ACIDS RESEARCH. 2011;39(8):3166-3175

Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate.

Ström CE; Johansson F; Uhlén M; Szigyarto CA-K; Erixon K; Helleday T
Article: EXPERIMENTAL CELL RESEARCH. 2011;317(3):330-337

Cohesin phosphorylation and mobility of SMC1 at ionizing radiation-induced DNA double-strand breaks in human cells.

Bauerschmidt C; Woodcock M; Stevens DL; Hill MA; Rothkamm K; Helleday T
Article: MOLECULAR CELL. 2011;41(2):210-220

miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors.

Moskwa P; Buffa FM; Pan Y; Panchakshari R; Gottipati P; Muschel RJ; Beech J; Kulshrestha R; Abdelmohsen K; Weinstock DM; Gorospe M; Harris AL; Helleday T; Chowdhury D
Article: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 2011;706(1-2):1-6

Transcription inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) causes DNA damage and triggers homologous recombination repair in mammalian cells.

Stoimenov I; Gottipati P; Schultz N; Helleday T
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2011;404(1):206-210

Repair pathways independent of the Fanconi anemia nuclear core complex play a predominant role in mitigating formaldehyde-induced DNA damage.

Noda T; Takahashi A; Kondo N; Mori E; Okamoto N; Nakagawa Y; Ohnishi K; Zdzienicka MZ; Thompson LH; Helleday T; Asada H; Ohnishi T
Article: ONCOTARGET. 2010;1(7):606-619

Homologous recombination repair is essential for repair of vosaroxin-induced DNA double-strand breaks.

Hawtin RE; Stockett DE; Wong OK; Lundin C; Helleday T; Fox JA
Article: MOLECULAR CELL. 2010;40(4):632-644

Identification of the MMS22L-TONSL complex that promotes homologous recombination.

Duro E; Lundin C; Ask K; Sanchez-Pulido L; MacArtney TJ; Toth R; Ponting CP; Groth A; Helleday T; Rouse J
Article: MUTAGENESIS. 2010;25(6):623-629

The XPD subunit of TFIIH is required for transcription-associated but not DNA double-strand break-induced recombination in mammalian cells.

Savolainen L; Cassel T; Helleday T
Article: CANCER RESEARCH. 2010;70(20):8045-8054

Contextual synthetic lethality of cancer cell kill based on the tumor microenvironment.

Chan N; Pires IM; Bencokova Z; Coackley C; Luoto KR; Bhogal N; Lakshman M; Gottipati P; Oliver FJ; Helleday T; Hammond EM; Bristow RG
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(37):16090-16095

Chk1 promotes replication fork progression by controlling replication initiation.

Petermann E; Woodcock M; Helleday T
Article: JOURNAL OF MOLECULAR BIOLOGY. 2010;402(1):70-82

Methylated DNA causes a physical block to replication forks independently of damage signalling, O(6)-methylguanine or DNA single-strand breaks and results in DNA damage.

Groth P; Ausländer S; Majumder MM; Schultz N; Johansson F; Petermann E; Helleday T
Article: DNA REPAIR. 2010;9(9):964-975

Human RECQL5 overcomes thymidine-induced replication stress.

Blundred R; Myers K; Helleday T; Goldman ASH; Bryant HE
Article: CANCER RESEARCH. 2010;70(15):6268-6276

6-thioguanine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance.

Issaeva N; Thomas HD; Djureinovic T; Jaspers JE; Stoimenov I; Kyle S; Pedley N; Gottipati P; Zur R; Sleeth K; Chatzakos V; Mulligan EA; Lundin C; Gubanova E; Kersbergen A; Harris AL; Sharma RA; Rottenberg S; Curtin NJ; Helleday T
Article: ONCOTARGET. 2010;1(3):175-184

Overexpression of POLQ confers a poor prognosis in early breast cancer patients.

Higgins GS; Harris AL; Prevo R; Helleday T; McKenna WG; Buffa FM
Article: CELL. 2010;142(1):65-76

Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2.

MacKay C; Déclais A-C; Lundin C; Agostinho A; Deans AJ; MacArtney TJ; Hofmann K; Gartner A; West SC; Helleday T; Lilley DMJ; Rouse J
Article: CANCER RESEARCH. 2010;70(13):5389-5398

Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells.

Gottipati P; Vischioni B; Schultz N; Solomons J; Bryant HE; Djureinovic T; Issaeva N; Sleeth K; Sharma RA; Helleday T
Article: DNA REPAIR. 2010;9(7):835-841

XRCC1 phosphorylation by CK2 is required for its stability and efficient DNA repair.

Parsons JL; Dianova II; Finch D; Tait PS; Ström CE; Helleday T; Dianov GL
Article: CARCINOGENESIS. 2010;31(6):955-960

Homologous recombination in cancer development, treatment and development of drug resistance.

Helleday T
Article: CANCER RESEARCH. 2010;70(7):2984-2993

A small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radiosensitization by POLQ knockdown.

Higgins GS; Prevo R; Lee Y-F; Helleday T; Muschel RJ; Taylor S; Yoshimura M; Hickson ID; Bernhard EJ; McKenna WG
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2010;285(11):8054-8060

PARP-3 is a mono-ADP-ribosylase that activates PARP-1 in the absence of DNA.

Loseva O; Jemth A-S; Bryant HE; Schüler H; Lehtiö L; Karlberg T; Helleday T
Article: JOURNAL OF CELL BIOLOGY. 2010;188(5):629-638

Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase.

Beck H; Nähse V; Larsen MSY; Groth P; Clancy T; Lees M; Jørgensen M; Helleday T; Syljuåsen RG; Sørensen CS
Article: MOLECULAR CELL. 2010;37(4):492-502

Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair.

Petermann E; Orta ML; Issaeva N; Schultz N; Helleday T
Article: DNA REPAIR. 2009;8(12):1424-1433

Specific targeted gene repair using single-stranded DNA oligonucleotides at an endogenous locus in mammalian cells uses homologous recombination.

McLachlan J; Fernandez S; Helleday T; Bryant HE
Article: NUCLEIC ACIDS RESEARCH. 2009;37(19):6400-6413

The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links.

Al-Minawi AZ; Lee Y-F; Håkansson D; Johansson F; Lundin C; Saleh-Gohari N; Schultz N; Jenssen D; Bryant HE; Meuth M; Hinz JM; Helleday T
Article: EMBO JOURNAL. 2009;28(17):2601-2615

PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination.

Bryant HE; Petermann E; Schultz N; Jemth A-S; Loseva O; Issaeva N; Johansson F; Fernandez S; McGlynn P; Helleday T
Article: NUCLEIC ACIDS RESEARCH. 2009;37(15):5105-5113

BRCA2-dependent homologous recombination is required for repair of Arsenite-induced replication lesions in mammalian cells.

Ying S; Myers K; Bottomley S; Helleday T; Bryant HE
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2009;52(9):3108-3111

Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3.

Lehtiö L; Jemth A-S; Collins R; Loseva O; Johansson A; Markova N; Hammarström M; Flores A; Holmberg-Schiavone L; Weigelt J; Helleday T; Schüler H; Karlberg T
Article: NUCLEIC ACIDS RESEARCH. 2009;37(2):405-412

Transcription-associated recombination is independent of XRCC2 and mechanistically separate from homology-directed DNA double-strand break repair.

Savolainen L; Helleday T
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2008;105(52):20752-20757

Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control.

Wilsker D; Petermann E; Helleday T; Bunz F
Article: CLINICAL CANCER RESEARCH. 2008;14(17):5476-5483

Thymidine selectively enhances growth suppressive effects of camptothecin/irinotecan in MSI+ cells and tumors containing a mutation of MRE11.

Rodriguez R; Hansen LT; Phear G; Scorah J; Spang-Thomsen M; Cox A; Helleday T; Meuth M
Article: MOLECULAR BIOLOGY OF THE CELL. 2008;19(9):3923-3933

WRN is required for ATM activation and the S-phase checkpoint in response to interstrand cross-link-induced DNA double-strand breaks.

Cheng W-H; Muftic D; Muftuoglu M; Dawut L; Morris C; Helleday T; Shiloh Y; Bohr VA
Article: JOURNAL OF APPLIED MICROBIOLOGY. 2008;105(1):290-299

Bacteriophage P2 integrase: another possible tool for site-specific recombination in eukaryotic cells.

Frumerie C; Sylwan L; Helleday T; Yu A; Haggård-Ljungquist E
Article: MOLECULAR BIOLOGY OF THE CELL. 2008;19(6):2373-2378

Claspin promotes normal replication fork rates in human cells.

Petermann E; Helleday T; Caldecott KW
Article: JOURNAL OF MOLECULAR BIOLOGY. 2008;379(1):136-145

Zinc binding catalytic domain of human tankyrase 1.

Lehtiö L; Collins R; van den Berg S; Johansson A; Dahlgren L-G; Hammarström M; Helleday T; Holmberg-Schiavone L; Karlberg T; Weigelt J
Article: MOLECULAR AND CELLULAR BIOLOGY. 2008;28(1):154-164

Transcription-associated recombination is dependent on replication in Mammalian cells.

Gottipati P; Cassel TN; Savolainen L; Helleday T
Article: NUCLEIC ACIDS RESEARCH. 2008;36(1):1-9

The ERCC1/XPF endonuclease is required for efficient single-strand annealing and gene conversion in mammalian cells.

Al-Minawi AZ; Saleh-Gohari N; Helleday T
Article: JOURNAL OF CELL BIOLOGY. 2007;179(7):1337-1345

The histone methyltransferase SET8 is required for S-phase progression.

Jørgensen S; Elvers I; Trelle MB; Menzel T; Eskildsen M; Jensen ON; Helleday T; Helin K; Sørensen CS
Article: JOURNAL OF MOLECULAR BIOLOGY. 2007;373(1):38-47

RPA mediates recombination repair during replication stress and is displaced from DNA by checkpoint signalling in human cells.

Sleeth KM; Sørensen CS; Issaeva N; Dziegielewski J; Bartek J; Helleday T
Article: MOLECULAR AND CELLULAR BIOLOGY. 2007;27(7):2562-2571

RAD18 and poly(ADP-ribose) polymerase independently suppress the access of nonhomologous end joining to double-strand breaks and facilitate homologous recombination-mediated repair.

Saberi A; Hochegger H; Szuts D; Lan L; Yasui A; Sale JE; Taniguchi Y; Murakawa Y; Zeng W; Yokomori K; Helleday T; Teraoka H; Arakawa H; Buerstedde J-M; Takeda S
Article: CYTOGENETIC AND GENOME RESEARCH. 2007;116(1-2):38-45

RAD51C (RAD51L2) is involved in maintaining centrosome number in mitosis.

Renglin Lindh A; Schultz N; Saleh-Gohari N; Helleday T
Article: DNA REPAIR. 2006;5(12):1449-1458

Caffeine delays replication fork progression and enhances UV-induced homologous recombination in Chinese hamster cell lines.

Johansson F; Lagerqvist A; Filippi S; Palitti F; Erixon K; Helleday T; Jenssen D
Article: NATURE. 2006;444(7119):633-637

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.

Bartkova J; Rezaei N; Liontos M; Karakaidos P; Kletsas D; Issaeva N; Vassiliou L-VF; Kolettas E; Niforou K; Zoumpourlis VC; Takaoka M; Nakagawa H; Tort F; Fugger K; Johansson F; Sehested M; Andersen CL; Dyrskjot L; Ørntoft T; Lukas J; Kittas C; Helleday T; Halazonetis TD; Bartek J; Gorgoulis VG
Article: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 2006;599(1-2):116-123

Homologous recombination is involved in repair of chromium-induced DNA damage in mammalian cells.

Bryant HE; Ying S; Helleday T
Article: HUMAN MOLECULAR GENETICS. 2006;15(7):1217-1224

Mitotic defects in XRCC3 variants T241M and D213N and their relation to cancer susceptibility.

Lindh AR; Rafii S; Schultz N; Cox A; Helleday T
Article: NUCLEIC ACIDS RESEARCH. 2006;34(6):1685-1691

Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.

Bryant HE; Helleday T
Article: CELL CYCLE. 2005;4(9):1176-1178

Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy.

Helleday T; Bryant HE; Schultz N
Article: MOLECULAR AND CELLULAR BIOLOGY. 2005;25(16):7158-7169

Spontaneous homologous recombination is induced by collapsed replication forks that are caused by endogenous DNA single-strand breaks.

Saleh-Gohari N; Bryant HE; Schultz N; Parker KM; Cassel TN; Helleday T
Article: NUCLEIC ACIDS RESEARCH. 2005;33(12):3799-3811

Methyl methanesulfonate (MMS) produces heat-labile DNA damage but no detectable in vivo DNA double-strand breaks.

Lundin C; North M; Erixon K; Walters K; Jenssen D; Goldman ASH; Helleday T
Article: MOLECULAR AND CELLULAR BIOLOGY. 2005;25(9):3553-3562

Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage.

Syljuåsen RG; Sørensen CS; Hansen LT; Fugger K; Lundin C; Johansson F; Helleday T; Sehested M; Lukas J; Bartek J
Article: NATURE. 2005;434(7035):913-917

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.

Bryant HE; Schultz N; Thomas HD; Parker KM; Flower D; Lopez E; Kyle S; Meuth M; Curtin NJ; Helleday T
Article: NATURE. 2005;434(7029):108-113

Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1.

El-Khamisy SF; Saifi GM; Weinfeld M; Johansson F; Helleday T; Lupski JR; Caldecott KW
Article: NATURE CELL BIOLOGY. 2005;7(2):195-201

The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair.

Sørensen CS; Hansen LT; Dziegielewski J; Syljuåsen RG; Lundin C; Bartek J; Helleday T
Article: CANCER RESEARCH. 2005;65(1):325-330

Up-regulation of the error-prone DNA polymerase {kappa} promotes pleiotropic genetic alterations and tumorigenesis.

Bavoux C; Leopoldino AM; Bergoglio V; O-Wang J; Ogi T; Bieth A; Judde J-G; Pena SDJ; Poupon M-F; Helleday T; Tagawa M; Machado C; Hoffmann J-S; Cazaux C
Article: ONCOGENE. 2004;23(56):9136-9141

Strand invasion involving short tract gene conversion is specifically suppressed in BRCA2-deficient hamster cells.

Saleh-Gohari N; Helleday T
Article: HUMAN MOLECULAR GENETICS. 2004;13(23):2937-2945

ATM is required for the cellular response to thymidine induced replication fork stress.

Bolderson E; Scorah J; Helleday T; Smythe C; Meuth M
Article: BIOCHEMICAL SOCIETY TRANSACTIONS. 2004;32(Pt 6):959-961

Poly(ADP-ribose) polymerase inhibitors as potential chemotherapeutic agents.

Bryant HE; Helleday T
Article: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 2004;563(1):35-47

Screening for genotoxicity using the DRAG assay: investigation of halogenated environmental contaminants.

Johansson F; Allkvist A; Erixon K; Malmvärn A; Nilsson R; Bergman A; Helleday T; Jenssen D
Article: NUCLEIC ACIDS RESEARCH. 2004;32(12):3683-3688

Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells.

Saleh-Gohari N; Helleday T
Article: ONCOGENE. 2004;23(13):2324-2329

p53 protects from replication-associated DNA double-strand breaks in mammalian cells.

Kumari A; Schultz N; Helleday T
Article: HUMAN MOLECULAR GENETICS. 2004;13(2):203-212

A tumour-derived mutant allele of XRCC2 preferentially suppresses homologous recombination at DNA replication forks.

Mohindra A; Bolderson E; Stone J; Wells M; Helleday T; Meuth M
Article: NUCLEIC ACIDS RESEARCH. 2003;31(17):4959-4964

Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination.

Schultz N; Lopez E; Saleh-Gohari N; Helleday T
Article: INTERNATIONAL JOURNAL OF CANCER. 2003;105(4):472-479

The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer.

Hansen LT; Lundin C; Spang-Thomsen M; Petersen LN; Helleday T
Article: JOURNAL OF MOLECULAR BIOLOGY. 2003;328(3):521-535

RAD51 is involved in repair of damage associated with DNA replication in mammalian cells.

Lundin C; Schultz N; Arnaudeau C; Mohindra A; Hansen LT; Helleday T
Article: LUNG CANCER. 2003;40(2):157-164

DNA repair rate and etoposide (VP16) resistance of tumor cell subpopulations derived from a single human small cell lung cancer.

Hansen LT; Lundin C; Helleday T; Poulsen HS; Sørensen CS; Petersen LN; Spang-Thomsen M
Article: CARCINOGENESIS. 2003;24(2):249-253

Reduced apoptotic response to camptothecin in CHO cells deficient in XRCC3.

Hinz JM; Helleday T; Meuth M
Article: HUMAN MOLECULAR GENETICS. 2002;11(18):2189-2200

Defects in homologous recombination repair in mismatch-repair-deficient tumour cell lines.

Mohindra A; Hays LE; Phillips EN; Preston BD; Helleday T; Meuth M
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2002;296(2):363-367

Overexpression of cyclin E does not influence homologous recombination in Chinese hamster cells.

Lundin C; Samuelsson MKR; Helleday T
Article: MOLECULAR AND CELLULAR BIOLOGY. 2002;22(16):5869-5878

Different roles for nonhomologous end joining and homologous recombination following replication arrest in mammalian cells.

Lundin C; Erixon K; Arnaudeau C; Schultz N; Jenssen D; Meuth M; Helleday T
Article: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 2001;493(1-2):55-66

ELF magnetic field affects proliferation of SPD8/V79 Chinese hamster cells but does not interact with intrachromosomal recombination.

Olsson G; Belyaev IY; Helleday T; Harms-Ringdahl M
Article: JOURNAL OF MOLECULAR BIOLOGY. 2001;307(5):1235-1245

DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells.

Arnaudeau C; Lundin C; Helleday T
Article: NUCLEIC ACIDS RESEARCH. 2001;29(3):662-667

RAD51 supports spontaneous non-homologous recombination in mammalian cells, but not the corresponding process induced by topoisomerase inhibitors.

Arnaudeau C; Rozier L; Cazaux C; Defais M; Jenssen D; Helleday T
Article: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 2000;461(3):221-228

Inhibition of DNA synthesis is a potent mechanism by which cytostatic drugs induce homologous recombination in mammalian cells.

Arnaudeau C; Tenorio Miranda E; Jenssen D; Helleday T
Article: ENVIRONMENTAL AND MOLECULAR MUTAGENESIS. 2000;35(2):114-122

Arsenic[III] and heavy metal ions induce intrachromosomal homologous recombination in the hprt gene of V79 Chinese hamster cells.

Helleday T; Nilsson R; Jenssen D
Article: JOURNAL OF MOLECULAR BIOLOGY. 1999;289(5):1231-1238

The RAD51 protein supports homologous recombination by an exchange mechanism in mammalian cells.

Arnaudeau C; Helleday T; Jenssen D
Article: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 1999;439(2):137-147

Brominated flame retardants induce intragenic recombination in mammalian cells.

Helleday T; Tuominen KL; Bergman A; Jenssen D
Article: JOURNAL OF MOLECULAR BIOLOGY. 1998;279(4):687-694

A partial hprt gene duplication generated by non-homologous recombination in V79 Chinese hamster cells is eliminated by homologous recombination.

Helleday T; Arnaudeau C; Jenssen D
Article: CARCINOGENESIS. 1998;19(6):973-978

Effects of carcinogenic agents upon different mechanisms for intragenic recombination in mammalian cells.

Helleday T; Arnaudeau C; Jenssen D
Show more

All other publications

Review: MOLECULAR ONCOLOGY. 2022;16(21):3792-3810

Targeting the DNA damage response and repair in cancer through nucleotide metabolism.

Helleday T; Rudd SG
Review: EXPERT REVIEWS IN MOLECULAR MEDICINE. 2022;24:e39

Precision oncology using ex vivo technology: a step towards individualised cancer care?

Williams ST; Wells G; Conroy S; Gagg H; Allen R; Rominiyi O; Helleday T; Hullock K; Pennington CEW; Rantala J; Collis SJ; Danson SJ
Editorial comment: CLINICAL AND TRANSLATIONAL MEDICINE. 2022;12(8):e1035

Synthetic switches of OGG1 control initiation of base excision repair and offer new treatment strategies.

Benitéz-Buelga C; Helleday T; Michel M
Meeting abstract: CANCER RESEARCH. 2022;82(10):pr016

The spatial landscape of clonal somatic mutations in benign and malignant tissue

Erickson A; Berglund E; He M; Marklund M; Mirzazadeh R; Schultz N; Bergenstrahle L; Kvastad L; Andersson A; Bergenstrahle J; Larsson L; Shamikh A; Basmaci E; De Stahl TD; Rajakumar T; Thrane K; Ji AL; Khavari PA; Tarish F; Tanoglidi A; Maaskola J; Colling R; Mirtti T; Hamdy FC; Woodcock DJ; Helleday T; Mills IG; Lamb AD
Editorial comment: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2022;142(3 Pt A):736-740.e6

Coexpression of MTH1 and PMS2 Is Associated with Advanced Disease and Disease Progression after Therapy in Melanoma.

Das I; Tuominen R; Helleday T; Hansson J; Warpman Berglund U; Egyházi Brage S
Editorial comment: CLINICAL CANCER RESEARCH. 2021;27(21):6066

Editor's Note: Castration Therapy Results in Decreased Ku70 Levels in Prostate Cancer.

Al-Ubaidi FLT; Schultz N; Loseva O; Egevad L; Granfors T; Helleday T
Editorial comment: NATURE CANCER. 2021;2(6):581-583

Polθ inhibitors unchained.

Helleday T
Meeting abstract: BLOOD. 2020;136:18-19

Karonudib Has Potent Anti-Tumor Effects in Preclinical Models of B-Cell Lymphoma

Oksvold MP; Berglund UW; Gad H; Bai B; Stokke T; Rein ID; Pham T; Sanjiv K; Oy GF; Norum JH; Smeland EB; Myklebust JH; Helleday T; Vatsveen TK
Meeting abstract: CANCER RESEARCH. 2020;80(16):5204

Targeting OGG1 arrest cancer cell proliferationby mitochondrial dysfunction and replication stress

Benitez-Buelga C; Visnes T; Sanjiv K; Mortusewicz O; Berglund UW; Helleday T
Meeting abstract: CANCER RESEARCH. 2020;80(16):4799

OGG1 depleted cancer cells are sensitive to anti-malarial drug proguanil: Repurposing for cancer treatment

Rajagopal V; Marimuthu K; Benitez-Buelga C; Wallner O; Homan E; Scobie M; Kalderen C; Helleday T; Berglund UW; Sanjiv K
Meeting abstract: CANCER RESEARCH. 2020;80(16):1057

Targeting MTHFD2 using first-in-class inhibitors kills haematological and solid cancer through thymineless-induced replication stress

Helleday T
Editorial comment: ANNALS OF ONCOLOGY. 2020;31(5):553-555

Managing COVID-19 in the oncology clinic and avoiding the distraction effect.

Cortiula F; Pettke A; Bartoletti M; Puglisi F; Helleday T
Corrigendum: ONCOTARGET. 2020;11(8):827

Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1.

Pudelko L; Rouhi P; Sanjiv K; Gad H; Kalderén C; Höglund A; Squatrito M; Schuhmacher AJ; Edwards S; Hägerstrand D; Berglund UW; Helleday T; Bräutigam L
Meeting abstract: CANCER RESEARCH. 2020;80(4):es12-2-es12-2

Targeted DNA repair in cancer and new NUDT5 inhibitors to block hormone signalling to target breast cancer

Helleday T
Corrigendum: CELL DEATH & DISEASE. 2020;11(2):99

Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma.

Einarsdottir BO; Karlsson J; Söderberg EMV; Lindberg MF; Funck-Brentano E; Jespersen H; Brynjolfsson SF; Bagge RO; Carstam L; Scobie M; Koolmeister T; Wallner O; Stierner U; Berglund UW; Ny L; Nilsson LM; Larsson E; Helleday T; Nilsson JA
Editorial comment: ANNALS OF ONCOLOGY. 2020;31(2):167-168

Using personalized immune-humanized xenograft mouse models to predict immune checkpoint responses in malignant melanoma: potential and hurdles.

Helleday T
Corrigendum: NATURE COMMUNICATIONS. 2019;10(1):5050

Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.

Page BDG; Valerie NCK; Wright RHG; Wallner O; Isaksson R; Carter M; Rudd SG; Loseva O; Jemth A-S; Almlöf I; Font-Mateu J; Llona-Minguez S; Baranczewski P; Jeppsson F; Homan E; Almqvist H; Axelsson H; Regmi S; Gustavsson A-L; Lundbäck T; Scobie M; Strömberg K; Stenmark P; Beato M; Helleday T
Meeting abstract: ANNALS OF ONCOLOGY. 2019;30:vii8

Therapeutic implications of MTH1 inhibitor TH1579 in cutaneous malignant melanoma

Das I; Gad H; Brautigam L; Pudelko L; Tuominen R; Hoiom V; Almlof I; Hansson J; Helleday T; Brage SE; Berglund UW
Meeting abstract: CANCER RESEARCH. 2019;79(13):105

MTH1 promotes mitotic progression to avoid oxidative DNA damage in cancer cells

Sanjiv K; Gad H; Rudd SG; Mortusewicz O; Stolz A; Amaral N; Brautigham L; Pudelko L; Kalderen C; Jemth A-S; Almlof I; Visnes T; Schultz N; Bostrom J; Montano JMC; Hagenkort A; Groth P; Gokturk C; Koolmeister T; Wakchaure P; Homan E; Altun M; Strom C; Scobie M; Bastians H; Berglund UW; Helleday T
Editorial comment: ANNALS OF ONCOLOGY. 2019;30(3):360-361

Making immunotherapy 'cold' tumours 'hot' by chemotherapy-induced mutations-a misconception.

Helleday T
Review: AMERICAN SOCIETY OF CLINICAL ONCOLOGY EDUCATIONAL BOOK / ASCO. AMERICAN SOCIETY OF CLINICAL ONCOLOGY. MEETING. 2019;39:185-195

The DNA Damaging Revolution: PARP Inhibitors and Beyond.

Yap TA; Plummer R; Azad NS; Helleday T
Review: EMBO REPORTS. 2018;19(9):e46263

Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments.

Liao H; Ji F; Helleday T; Ying S
Meeting abstract: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2018;138(5):S200

Effects of MTH1 inhibitor TH1579 on cutaneous melanoma

Das I; Gad H; Pudelko L; Brautigam L; Tuominen R; Helleday T; Hansson J; Brage S; Berglund U
Corrigendum: JOURNAL OF MEDICINAL CHEMISTRY. 2017;60(17):7614

Correction to Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors.

Llona-Minguez S; Höglund A; Ghassemian A; Desroses M; Calderón-Montaño JM; Burgos Morón E; Valerie NCK; Wiita E; Almlöf I; Koolmeister T; Mateus A; Cazares-Körner C; Sanjiv K; Homan E; Loseva O; Baranczewski P; Darabi M; Mehdizadeh A; Fayezi S; Jemth A-S; Warpman Berglund U; Sigmundsson K; Lundbäck T; Jenmalm Jensen A; Artursson P; Scobie M; Helleday T
Editorial comment: ANNALS OF ONCOLOGY. 2017;28(9):2054-2055

Chemotherapy-induced toxicity-a secondary effect caused by released DNA?

Helleday T
Editorial comment: ANNALS OF ONCOLOGY. 2017;28(7):1407-1408

CHD1: a new treatment biomarker for recombination deficiency in castration resistant prostate cancer?

Helleday T
Corrigendum: NATURE. 2017;544(7651):508

Corrigendum: MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.

Gad H; Koolmeister T; Jemth A-S; Eshtad S; Jacques SA; Ström CE; Svensson LM; Schultz N; Lundbäck T; Einarsdottir BO; Saleh A; Göktürk C; Baranczewski P; Svensson R; Berntsson RP-A; Gustafsson R; Strömberg K; Sanjiv K; Jacques-Cordonnier M-C; Desroses M; Gustavsson A-L; Olofsson R; Johansson F; Homan EJ; Loseva O; Bräutigam L; Johansson L; Höglund A; Hagenkort A; Pham T; Altun M; Gaugaz FZ; Vikingsson S; Evers B; Henriksson M; Vallin KSA; Wallner OA; Hammarström LGJ; Wiita E; Almlöf I; Kalderén C; Axelsson H; Djureinovic T; Carreras Puigvert J; Häggblad M; Jeppsson F; Martens U; Lundin C; Lundgren B; Granelli I; Jenmalm Jensen A; Artursson P; Nilsson JA; Stenmark P; Scobie M; Ulrika Warpman Berglund &Thomas Helleday
Meeting abstract: MOLECULAR CANCER RESEARCH. 2017;15:IA12

Poisoning cancer with oxidized nucleotides by targeting MTH1

Helleday T
Corrigendum: CELL REPORTS. 2016;17(12):3407-3416

Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities.

Sanjiv K; Hagenkort A; Calderón-Montaño JM; Koolmeister T; Reaper PM; Mortusewicz O; Jacques SA; Kuiper RV; Schultz N; Scobie M; Charlton PA; Pollard JR; Berglund UW; Altun M; Helleday T
Meeting abstract: TOXICOLOGY LETTERS. 2016;258:S57

Introducing a new method for absolute quantification of DNA repair proteins in relation to drug development: LC-MS/MS with isotope dilution

Coskun E; Jaruga P; Jemth A; Loseva O; Leona SD; Tona A; Lowenthal MS; Reddy PT; Helleday T; Dizdaroglu M
Review: DNA REPAIR. 2016;44:193-204

Pathways controlling dNTP pools to maintain genome stability.

Rudd SG; Valerie NCK; Helleday T
Meeting abstract: CANCER RESEARCH. 2016;76:1260

Polymerase kappa determines the sensitivity of MTH1 inhibitors to cisplatin-resistant cell

Sanjiv K; Gad H; Rudd S; Hurley R; Herr P; Montano JMC; Mortusewicz O; Koolmeister T; Jaques S; Moron EB; Hoglund A; Lee T-C; Scobie M; Kaufmann S; Weroha J; Berglund UW; Hendrickson AW; Helleday T
Meeting abstract: CANCER RESEARCH. 2016;76:lb-176-lb-176

The human androgen receptor regulates DNA damage response (DDR) in prostate cancer

Asim M; Zecchini H; Tarish F; Massie C; Baridi A; Warren A; Zhao W; McDuffus L-A; Mascalchi P; Shaw G; Dev H; Wadhwa K; Wijnhoven P; Forment J; Lyons S; Lynch A; O'Neill C; Zecchini V; Rennie P; Baniahmad A; Tavare S; Mills I; Schulz N; Galanty Y; Helleday T; Neal D
Editorial comment: SCIENCE. 2016;352(6290):1178-1179

DNA REPAIR. Drugging DNA repair.

Jackson SP; Helleday T
Editorial comment: ANNALS OF ONCOLOGY. 2016;27(5):755-757

PARP inhibitor receives FDA breakthrough therapy designation in castration resistant prostate cancer: beyond germline BRCA mutations.

Helleday T
Review: RECOMBINANT PROTEIN EXPRESSION: PROKARYOTIC HOSTS AND CELL-FREE SYSTEMS. 2016;566:305-332

Production, Purification, and Characterization of ¹⁵N-Labeled DNA Repair Proteins as Internal Standards for Mass Spectrometric Measurements.

Reddy PT; Jaruga P; Nelson BC; Lowenthal MS; Jemth A-S; Loseva O; Coskun E; Helleday T; Dizdaroglu M
Review: FEBS JOURNAL. 2016;283(2):232-245

Targeting DNA repair, DNA metabolism and replication stress as anti-cancer strategies.

Puigvert JC; Sanjiv K; Helleday T
Corrigendum: MOLECULAR CELL. 2016;61(1):181

Timeless Interacts with PARP-1 to Promote Homologous Recombination Repair (vol 60, pg 163, 2015)

Xie S; Mortusewicz O; Ma HT; Herr P; Poon RYC; Helleday T; Qian C
Editorial comment: NEW ENGLAND JOURNAL OF MEDICINE. 2015;373(16):1570-1571

Poisoning Cancer Cells with Oxidized Nucleosides.

Helleday T
Review: PROGRESS IN LIPID RESEARCH. 2015;58:51-75

Lysophosphatidic acid receptor (LPAR) modulators: The current pharmacological toolbox.

Llona-Minguez S; Ghassemian A; Helleday T
Meeting abstract: ANNALS OF ONCOLOGY. 2015;26:9

MTH1 INHIBITORS IN CANCER TREATMENT

Helleday T
Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2014;50:81

The combination of Chk-1 and ATR inhibitor synergistically kills cancer cells

Sanjiv K; Hagenkort A; Reaper PM; Koolmeister T; Mortusewicz O; Schultz N; Scobie M; Berglund UW; Charlton PA; Pollard JR; Helleday T
Review: NATURE REVIEWS GENETICS. 2014;15(9):585-598

Mechanisms underlying mutational signatures in human cancers.

Helleday T; Eshtad S; Nik-Zainal S
Editorial comment: ANNALS OF ONCOLOGY. 2014;25(7):1253-1255

Cancer phenotypic lethality, exemplified by the non-essential MTH1 enzyme being required for cancer survival.

Helleday T
Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2014;50:s87

The interplay between the redox environment, MTH1 and cancer

Braeutigam L; Fiskesund R; Warpman-Berglund U; Helleday T
Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2014;50:S3

Targeting MTH1 prevents sanitation of oxidised dNTP pools and causes cancer-selective DNA damage and cell death

Helleday T
Review: EXPERT REVIEWS IN MOLECULAR MEDICINE. 2014;16:e10

Chemical strategies for development of ATR inhibitors.

Llona-Minguez S; Höglund A; Jacques SA; Koolmeister T; Helleday T
Corrigendum: MOLECULAR CELL. 2014;53(1):162-163

miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors (vol 41, pg 210, 2011)

Moskwa P; Buffa FM; Pan Y; Panchakshari R; Gottipati P; Muschel RJ; Beech J; Kulshrestha R; Abdelmohsen K; Weinstock DM; Gorospe M; Harris AL; Helleday T; Chowdhury D
Editorial comment: NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2013;20(12):1348-1350

PrimPol breaks replication barriers.

Helleday T
Meeting abstract: MOLECULAR CANCER THERAPEUTICS. 2013;12(11):cn05-04-cn05-04

Novel DNA repair targets for anticancer treatments

Helleday T
Review: CURRENT OPINION IN ONCOLOGY. 2013;25(6):609-614

Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practice.

Helleday T
Corrigendum: NATURE. 2013;500(7463):490

Replication stress links structural and numerical cancer chromosomal instability (vol 494, pg 492, 2013)

Burrell RA; McClelland SE; Endesfelder D; Groth P; Weller M-C; Shaikh N; Domingo E; Kanu N; Dewhurst SM; Gronroos E; Chew SK; Rowan AJ; Schenk A; Sheffer M; Howell M; Kschischo M; Behrens A; Helleday T; Bartek J; Tomlinson IP; Swanton C
Editorial comment: EMBO JOURNAL. 2013;32(4):493-495

Early replication fragile sites: where replication-transcription collisions cause genetic instability.

Mortusewicz O; Herr P; Helleday T
Corrigendum: JOURNAL OF BIOLOGICAL CHEMISTRY. 2012;287(41):34494

PARP-3 is a mono-ADP-ribosylase that activates PARP-1 in the absence of DNA.
Corrigendum: NUCLEIC ACIDS RESEARCH. 2012;40(12):5794

Methyl methanesulfonate (MMS) produces heat-labile DNA damage but no detectable in vivo DNA double-strand breaks
Meeting abstract: TOXICOLOGY LETTERS. 2012;211:S9

DNA repair pathways as target for cancer therapy

Helleday T
Review: CURRENT MOLECULAR PHARMACOLOGY. 2012;5(1):54-67

Biological relevance of DNA polymerase β and translesion synthesis polymerases to cancer and its treatment.

Nicolay NH; Helleday T; Sharma RA
Editorial comment: RADIATION RESEARCH. 2011;176(3):412-414

New translational possibilities for microenvironmental modulation of radiosensitivity.

Glazer PM; Le Q-T; Bristow R; Helleday T; Pelroy R; Bernhard EJ
Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2011;47:s58

PARP Inhibitors Sensitivity and Resistance

Helleday T
Review: MOLECULAR ONCOLOGY. 2011;5(4):387-393

The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings.

Helleday T
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2010;8(7):106

POLQ (DNA polyermase theta) as a novel therapeutic target: preclinical and clinical data

Higgins GS; Prevo R; Lundin C; Helleday T; Buffa FM; Harris AL; Muschel RJ; Bernhard EJ; Hickson ID; McKenna WG
Review: NATURE REVIEWS MOLECULAR CELL BIOLOGY. 2010;11(10):683-687

Pathways of mammalian replication fork restart.

Petermann E; Helleday T
Review: TRENDS IN PHARMACOLOGICAL SCIENCES. 2010;31(8):372-380

Targeting homologous recombination repair defects in cancer.

Evers B; Helleday T; Jonkers J
Meeting abstract: CHEMISTRY AND PHYSICS OF LIPIDS. 2010;163:s36

Anti-proliferative effects of taurine conjugated fatty acids

Chatzakos V; Slatis K; Djureinovic T; Helleday T; Hunt MC
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2010;8(5):156

Homologous recombination in cancer development, treatment and development of drug resistance

Helleday T
Corrigendum: CANCER RESEARCH. 2010;70(9):3853

A Small Interfering RNA Screen of Genes Involved in DNA Repair Identifies Tumor-Specific Radiosensitization by POLQ Knockdown

Higgins GS; Prevo R; Lee Y-F; Helleday T; Muschel RJ; Taylor S; Yoshimura M; Hickson ID; Bernhard EJ; McKenna WG
Meeting abstract: CANCER RESEARCH. 2010;70:3932

Loss of PTEN sensitizes cells to DNA damaging agents in a RAD51-independent manner

Fraser ME; Zhao H; Lundin C; Evans A; Helleday T; Bristow RG
Editorial comment: CURRENT BIOLOGY. 2010;20(2):R57-R58

Mutagenesis: mutating a gene while reading it.

Helleday T
Meeting abstract: BREAST CANCER RESEARCH. 2010;12(Suppl 1):p52-S16

Radiotherapy fraction size sensitivity is modulated by DNA repair systems

Somaiah N; Yarnold J; Daley F; Pearson A; Rothkamm K; Helleday T
Meeting abstract: MOLECULAR CANCER THERAPEUTICS. 2009;8(12):a115

Contextual synthetic lethality: Repair-deficient hypoxic tumor cells are sensitized to poly(ADP-ribose) polymerase (PARP) inhibition

Chan N; Fires IM; Bencokova Z; Coackley C; Bhogal N; Lakshman M; Gottipati P; Oliver FJ; Helleday T; Hammond EM; Bristow RG
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2009;7(2):39

Exploiting cancer defects in targeted therapy

Helleday T
Meeting abstract: CHEMISTRY AND PHYSICS OF LIPIDS. 2009;160:s23

Anti-proliferative effects of glycine conjugated fatty acids

Chatzakos V; Djureinovic T; Helleday T; Hunt M
Published conference paper: BIOCHEMICAL SOCIETY TRANSACTIONS. 2009;37(Pt 3):605-613

PCNA on the crossroad of cancer.

Stoimenov I; Helleday T
Review: MUTAGENESIS. 2009;24(3):203-210

Transcription-associated recombination in eukaryotes: link between transcription, replication and recombination.

Gottipati P; Helleday T
Review: EUROPEAN JOURNAL OF CANCER. 2008;44(7):921-927

Amplifying tumour-specific replication lesions by DNA repair inhibitors - a new era in targeted cancer therapy.

Helleday T
Review: NATURE REVIEWS CANCER. 2008;8(3):193-204

DNA repair pathways as targets for cancer therapy.

Helleday T; Petermann E; Lundin C; Hodgson B; Sharma RA
Published conference paper: BIOCHEMICAL SOCIETY TRANSACTIONS. 2007;35(Pt 5):1352-1354

DNA replication-associated lesions: importance in early tumorigenesis and cancer therapy.

Petermann E; Helleday T
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2007;5(4):33

DNA replication repair: molecular insights towards new approaches to targeted anti-cancer therapy

Helleday T
Review: DNA REPAIR. 2007;6(7):923-935

DNA double-strand break repair: from mechanistic understanding to cancer treatment.

Helleday T; Lo J; van Gent DC; Engelward BP
Corrigendum: NATURE. 2007;447(7142):346

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase (vol 434, pg 913, 2005)

Bryant HE; Schultz N; Thomas HD; Parker KM; Flower D; Lopez E; Kyle S; Meuth M; Curtin NJ; Helleday T
Review: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 2003;532(1-2):103-115

Pathways for mitotic homologous recombination in mammalian cells.

Helleday T
Published conference paper: ATLA-ALTERNATIVES TO LABORATORY ANIMALS. 2001;29(3):233-241

The DRAG test: an assay for detection of genotoxic damage.

Helleday T; Johansson F; Jenssen D
Published conference paper: TOXICOLOGY IN VITRO. 1998;12(5):519-522

Session 1: signal transduction.

Helleday T
Show more

Employments

Professor, Department of Oncology-Pathology, Karolinska Institutet, 2018-

Degrees and Education

Docent, Stockholm University

Supervisor

Johan Boström, Studying the Cell Cycle using Systems Biology and High Content Characterization of the Ubiquitin Proteasome System., https://openarchive.ki.se/xmlui/handle/10616/47323, 2014
Saeed Eshtad, Targeting DNA repair Pathways for Cancer Therapy., https://openarchive.ki.se/xmlui/handle/10616/45467, 2012

About me

Articles

All other publications

Employments

Degrees and Education

Supervisor

News from KI

Events from KI